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1. INTRODUCTION 
 
1.1 ANALYTICAL CHEMISTRY                                      (Gary.D.Christian, 2007) 
Analytical chemistry is the science that seeks ever improved means of measuring 
the chemical composition of natural and artificial materials. Analytical chemistry is a sub 
discipline of chemistry  has the broad mission of understanding the chemical composition 
of all matter and developing the tools to elucidate composition of new compounds. 
Types 
Traditionally, analytical chemistry split into two types, Quantitative and                         
Qualitative 
Quantitative and Qualitative 
Quantitative analysis seeks to establish the amount of a given element or 
compound in a sample. Qualitative analysis seeks to establish the presence of a given 
element, given functional group or inorganic or organic compound in a sample 
CHEMICAL ANALYSIS CLASSIFIED AS                      (Skoog, 2005) 
1. Clinical analysis 
2. Industrial analysis 
3. Bio chemical analysis 
4. Cosmetic analysis 
5. Medicinal analysis 
6. Agriculture analysis 
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MOLECULAR ANALYSIS CLASSIFIED AS                         (Chatwal, 2006) 
      1. Nuclear magnetic resonance 
2.   Intra red spectra copy 
3. Ultra violet absorption 
4. Ultra violet fluorescence 
5. Spectrophotometric analysis 
6. X-ray diffraction 
7.   X-ray absorption 
8. Radio tracer techniques 
9. Mass spectrometry 
10. Thermal analysis 
11. Gas chromatography 
12. Liquid chromatography 
13.Electron microscopy 
MORDEN ANALYTICAL CHEMISTRY                (Kausture, 2007) 
• Involves usage of microprocessor, computers, amplifiers and integrated circuits to 
make the process.       
• The branches of atomic spectroscopy including optical absorption, optical, emission 
and optical fluorescence, spectrometry, atomic mass spectrometry and atomic x-ray 
spectrometry. 
• The branches of atomic spectroscopy including optical absorption, optical emission, 
and optical fluorescence spectrometry, atomic mass spectrometry, and atomic x-ray 
spectrometry. 
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• In the field of analysis the most important this impossible makes new idea in the 
pharmaceutical development. 
• The accuracy of the calculating value by the most of instrument high qualified like 
chromatogram, in microgram. 
• The tools we need in analytical chemistry to answering the basic knowledge for the 
type of question. 
METHOD DEVELOPMENT 
Analytical methods Development and Validation plays an important role in 
the discovery, development, and Manufacture of Pharmaceuticals 
Pharmaceutical products formulated with more than one drug, typically referred 
to as combination products, are intended to meet previously unmet patients need by 
combining the therapeutic effects of two or more drugs in one product. These 
combination products can present daunting challenges to the analytical chemist 
responsible for the development and Validation of Analytical methods. This presentation 
will discuss the development and Validation of Analytical method (Spectrophotometric & 
High performance thin layer chromatography for drug products containing more than one 
active ingredient. The official test methods that result from these processes are used by 
quality control laboratories to ensure the identity, purity, potency, and performance of 
drug products. 
SELECTION OF ANALYTICAL TECHNIQUES         (mendham J et al., 2002) 
1. Proximate analysis : Determines the amount of each element in a sample. 
2. Partial analysis       : Determines selected constituents in the sample. 
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3. Trace constituents analysis : Determines specified components present in very 
minute quantity. 
4. Complete analysis : Determine the portion of each component in the sample. 
 
PHASES IN ANALYTICAL CHEMISTRY                        (Gary, 2007) 
Phase 1: Fast screening phase eg : Immuno assay, gas chromatography and liquid        
chromatography. 
Phase 2 :  Identification phase eg : GC – MS. 
Phase 3 : Qualification phase eg : Spectrophotometer and gas chromatography. 
 
IMPORTANT CONSIDERATIONS IN ANALYTICAL METHODS                         
(Willard, 1986) 
The instrument most visible and exciting element of the analytical method, only 
one component of the total analysis. 
• The analyst should determine the nature of the sample, the end use of the 
analytical results, the species to be analyzed. 
• Quantitative information may include elemental composition, oxidation state, 
functional groups, major components, minor components, complete identification 
in the given sample. 
• Quantitative data include accuracy and precision, range of expected analyte. 
• Methods such as controlling the atmosphere to which the sample is exposed, 
controlling the temperature of the sample, buffering the pH of sample solutions. 
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SENSITIVITY AND DETECTION LIMITS                          (Y.R. Sharma, 2009) 
TECHNIQUES DETECTION LIMITS 
IDENTIFICATION 
LIMITS 
Gas chromatography 
Infrared 
spectrophotometry 
Ultraviolet spectroscopy 
N.M.R(time averaged) 
Mass spectrometry          
(batch inlet) 
Mass spectrometry         
(direct probe ) 
10-6-1012
10-7 
10-7 
10-7 
10-6 
 
10-12 
- 
10-6 
10-6 
10-5 
10-5 
 
10-11 
 
FACTORS AFFECTING THE ANALYTICAL METHOD  
      (mendham J et al., 2002) 
• Problems arising from the nature of the material to be investigate (eg) radioactive 
substance affected by water. 
• Possible interference from components of the material other than those of interest. 
• The concentration range to be investigated. 
• The accuracy required. 
• The facilities available, particularly the instruments. 
• The number of analyses of similar type which have to be performed. 
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PHYSICAL PROPERTIES USED IN ANALYTICAL CHEMISTRY (Skoog, 2005) 
 
S. No 
Physical Property 
Measured 
Instrumental methods based on measurement of 
property 
1. Absorbtion of radiation Spectrophotometry 
2. Emission of radiation 
Emission spectroscopy, flame photometry, radio 
chemical method. 
3. Scattering of radiation Turbidometry, nephelometry 
4. Refraction of radiation Refractometry, interfero 
5. Diffraction of radiation X-ray, electron diffraction 
6. Rotation of radiation Polarimetry, optical rotatory dispersion. 
7. Electrical potential Potentiometry 
8. Electrical conductance Conductivity 
9. Quantity of electricity Coulometer 
10. Mass-to-charge ratio Mass spectroscopy 
11. Electrical current Polargraphy 
12. Thermal properties Thermal conductivity 
 
STAGES IN CHEMICAL ANALYSIS                    (mendham J et al., 2002) 
Evaluation of the satisfactory results 
The nature of the physical and chemical system may difficult in analytical 
chemist. Example, all over the chemist can provide problem of dissolution and separation 
of a multi-component high temperature among or with separation of a mixture of all 
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amino acids. He may also be asked to analyse polluted air or the insecticides in fish, 
birds, plants or animal to measure the rate of reaction, or to determine the number of 
electrons and intermediates involved in an electro chemical reaction 
Basic criteria for new method development of drug analysis: 
• The drug or drug combination may not be official in any Pharmacopoeias 
• A proper analytical procedure for the drug may not be available in the literature 
due to patent regulations 
• Analytical methods may not be available for the drug in the form of a formulation 
due to the interference caused by the formulation excipients 
• Analytical methods for the quantization of the drug in biological fluids may not 
be available 
• Analytical methods for a drug in combination with other drugs may not be 
available 
• The existing analytical procedures may require expensive reagents and solvents. It 
may also involve cumbersome extraction and separation procedures and these may not be 
reliable 
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SPECTROSCOPY   (Sharma Y.R, 2009) 
 Spectrophotometry is based upon the measurement and interpretation of 
electromagnetic radiation absorbed, when the molecules or atoms or ions of a sample 
due to electronic transition within the molecule. Every atom, ion or molecule has a 
unique characteristic relation with electromagnetic radiation 
Introduction to Spectrophotometric Methods of Analysis for Drugs in Combination 
Simultaneous estimation of drug combination is generally done by separation 
using chromatographic methods like HPLC, GC etc. These methods are accurate and 
precise with good reproducibility, but the cost of analysis is quite high owing to 
expensive instrumentation, reagent and expertise.  Hence it is worthwhile to develop 
simpler and cost effective method for simultaneous estimation of drugs for routine 
analysis of formulation. Spectrophotometric analysis fulfils such requirement where the 
simultaneous estimation of the drug combination can be done with similar effectiveness 
as that of chromatographic methods. 
The spectrophotometric assay of drugs rarely involves the measurement of 
absorbance of samples containing only one absorbing component. The pharmaceutical 
analyst frequently encounters the situation where the concentration of one or more 
substances is required in samples known to contain other absorbing substances, which 
potentially interfere in the assay. If the formula of the samples is known, the identity and 
concentration of the interfering substance are known and the extent of interference in the 
assay may be determined. 
The basis of all the spectrophotometric techniques for multicomponent samples is 
the property that at all wavelengths, 
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• The absorbance of a solution is the sum of absorbance of the individual 
components 
• The measured absorbance is the difference between the total absorbance of the 
solution in the sample cell and that of the solution in the reference cell 
• There are various spectrophotometric methods are available which can be used for 
the analysis of a combination samples. Following methods can be used Simultaneous 
equation method 
• Derivative spectrophotometric method 
• Absorbance ratio method ( Q-Absorbance method) 
• Difference Spectrophotometry 
• Solvent extraction method 
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1.2 ULTRAVIOLET SPECTROSCOPY 
 
INTRODUCTION          (Kalsi, 2007; Y.R.Sharma, 2009) 
Ultraviolet spectroscopy deals with the measurement of energy absorbed when 
electrons are promoted to higher energy levels. On passing electromagnetic radiation in 
the ultraviolet and visible regions through a compound with multiple bonds, a portion of 
the radiation is normally absorbed by the compound.  The amount of absorption depends 
on the wavelength of the radiation and the structure of the compound. Absorption of 
electromagnetic radiation in the visible and ultraviolet regions of the spectrum resulting 
in changes in the electronic structure of ions and molecules. 
Ultraviolet spectrum records the wavelength of an absorption maximum, i.e. 
λmax and the strength of the absorption, i.e. molar absorptivity (extinction co-efficient 
Σmax) as defined by the combined Beer-Lambert law. 
The ultraviolet spectrum will be divided into the following region. 
      1.Far (or vacuum) ultra violet Æ 10 – 200 nm 
2.Near or quartz ultraviolet Æ  200 – 380 nm 
3.Visible region Æ  380 – 780 nm 
The visible region corresponds to 400-800 nm and ultraviolet region to 200-400 nm. 
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INSTRUMENTAL MODULES FOR MEASURING ABSORPTION OF UV 
RADIATION                (Willard, 1986) 
 
 
 
 
 
 
 
 
ABSORPTION SPECTROSCOPY DEPENDS UPON THE FOLLOWING 
PARAMETERS  (A.H.Beckett, and J.B.Stenlake, 2007; Douglas, 2005; 
Willard, et.al., 1986) 
1) TRANSMITTANCE (T) 
It is the ratio of intensity of transmitted light to that of incident light 
T =   It / Io 
2) ABSORBANCE (A) 
It is negative logarithm of transmittance to the base 10 
A= -log 10 =   log 10 Io/ It 
A= abc 
3) MOLAR ABSORPTIVITY ( ε ) 
When concentration ‘’c’’in equation A=abc is expressed in mole/lit and cell 
length in  
Sample 
Radiant 
source  Solvent 
Photo 
detector
Wavelength 
selector
Read out Device 
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‘’cm ‘’ then absorptivity is called as molar absorptivity. 
ε =A/bc 
4) BEER –LAMBER’S LAW              (Jagmohan, 2006) 
It can be stated as the intensity of beam of monochromatic light. When passed 
through transparent medium decreases exponentially as the thickness and concentration 
of absorbing media increases arithmetically. 
Log10 ∑ ==⎟⎠
⎞⎜⎝
⎛ Acl
I
I 0
 
Where, Io - Intensity of incident light 
I - Intensity of emerged light 
Σ - Molar absorptivity 
c - Concentration of solute in moles/litre 
l - Path length (Cm) 
A - Absorbance 
LIMITATIONS OF BEER-LAMBERT’S LAW 
The Beer-Lambert law is rigorously obsessed provided a single species gives 
rise to the observed absorption.  However the law may not obsessed when, 
i) Different forms of the absorbing molecules are in equilibrium. 
ii) Solute and solvent from association complexes. 
iii) There is a thermal equilibrium between ground electronic state 
and a low lying excited state. 
13 
 
iv) The compounds are charged by irradiation (fluorescent 
compounds). 
DEVIATIONS FROM BEER’S LAW                        (B.K.Sharma, 2007) 
According to Beer’s law, a straight line passing through the origin should be 
obtained, when a graph is plotted between absorbance (A) and concentration. Deviation 
from the law may be positive or negative, according to whether the resulting curve is 
concave upwards or concave downwards as shown in the following figure. 
 
 
 
 
 
 
The deviations from the Beer’s law may be due to interaction of the solute molecules 
with each other or with the solvent or may be due to instrumental factors. 
The most important reasons that cause deviations are 
1.  Negative deviation can always be expected when the illumination is not 
 monochromatic. 
2. The presence of impurities that fluoresces or absorb at the required absorption 
wavelength. 
3. Environmental errors such as solvent, temperature and pressure. 
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4. Chemical factors such as change in pH and chemical equilibrium, presence of  
complexing agent, competitive metal ion reactions and concentration 
dependence. 
5. Refractive index of sample. 
6. Instrumental errors such as radiation, stability of radiation source, stability of 
slit control and electronics and reliability of the optical parts. 
IMPORTANT CHARACTERSTICS OF SPECTROPHOTOMETRIC AND 
PHOTOMETRIC METHODS INCLUDE 
• Wide applicability to both organic and inorganic systems. 
• Typical  sensitivities of 10 -4 to 10-5 
• Moderate to high selectivity. 
• Good accuracy. 
• Ease and convenience of data acquisition. 
 
CHOICE OF SOLVENT                (Jagmohan, 2006) 
• The solvent used should be of high purity, generally referred to as spectro grade 
• Care should be taken to keep lint and dust from contaminating the final 
solutions 
• A good solvent should be transparent over the desired range of wavelengths 
• Another factor pertains to the fine structure of an absorption band depends on 
the  polarity of the solvent 
• A solvent should be chosen so that it does not react chemically with the sample 
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SOLVENT EFFECTS         (William Kemp, 1996) 
The position and intensity of an absorption band may shift when the spectrum is 
recorded in different solvents. For changes to solvents of increased polarity we can 
summarize the normal pattern of shifts as follows. 
1. Conjugated dienes and aromatic hydrocarbons experience very little solvent 
shift. 
2. α,β unsaturated carbonyl compounds show two different shifts. 
i) The π - π* bond moves to longer wave length (red shift) 
ii) The n - π* bond moves to shorter wavelength (blue shift) 
FOLLOWING TABLE GIVES A LIST OF COMMON SOLVENTS USED IN UV 
SPECTROSCOPY                          (Jagmohan 2006) 
 
S.NO SOLVENT 
CUT-OFF WAVELENGTH 
(λ max nm) 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
Acetonitrile 
Acetone 
Benzene 
Benzonitrile 
Chloroform 
Carbon tetra chloride 
Cyclohexane 
Dioxane 
Ethanol 
Ethyl ether 
Heptane 
Hexane 
210 
330 
280 
300 
245 
265 
210 
225 
210 
210 
210 
210 
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13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
Iso -octane 
Methanol 
n- butanol 
N-N dimethyl formamide 
Nitro methane 
Pyridine 
Water 
Xylene 
210 
215 
210 
270 
380 
305 
210 
295 
 
WAVELENGTH CHOICE               (Robert D Braun, 2006) 
When choosing a wavelength at which to make an absorbance measurement, 
three factors must be considered. 
Factor 1 
If the solution contains more than one absorbing species, the wavelength that 
should be chosen, whenever possible, is that at which the second species in the solution 
does not absorb radiation. 
Factor 2 
It must be considered when a wave length is chosen is the required sensitive of 
the assay. 
Factor 3 
This factor to be considered is the sensitive of the assay to small changes in 
wave length it is preferable to choose a wavelength at which the absorbance will not be 
significantly altered if the wavelength is slightly changed. 
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DETECTORS           (B.K. Sharma, 2007; Willard, 1986) 
A detector is a transducer that convert electromagnetic radiation into an electron flow 
and subsequently, into a current flow or voltage in the readout circuit. Photoelectric or 
photo multiplier tubes are generally used as detectors. 
The detector must have the following important requirements. 
a) It must respond to radiant energy over a broad wavelength range. 
b) It should be sensitive to low levels of radiant power. 
c) It should rapidly respond to the radiation and produce an electrical signal that     can 
be readily amplified. 
d) It should have relatively low noise level (for stability). 
e) The signal produced is directly proportional to the power of beam striking it. 
QUALITATIVE ANALYSIS     (A.H.Beckett, and J.B.Stenlake, 2007) 
 The assay of an absorbing substance may be quickly carried out by preparing a 
solution in a transparent solvent and measuring its absorbance at a suitable wavelength. 
The wavelength normally selected is a wavelength of maximum absorption (λmax) 
where small errors in setting the wavelength scale have little effects on the measured 
absorbance. 
QUANTITATIVE ANALYSIS 
 Absorption spectroscopy is one of the most useful tools to access for the 
quantitative analysis, the most important characteristics of photometric and 
spectrophotometric methods are high selectivity and ease of convenience. Quantitative 
analysis of a single component can be done using following methods. 
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1. Use of A (1%, 1cm) values. 
2. Use of calibration graph (multiple standard methods). 
3. By single or double point standardization method. 
USE OF A (1%, 1CM) VALUES 
 This method can be used for the estimation from formulation or raw material 
when reference standard not available. The use of standard A (1%, 1cm) value avoids 
the need to prepare a standard solution of the reference substance in order to determine 
its absorption. 
USE OF CALIBRATION GRAPH 
In this method absorbance of a number of standard solutions of reference 
substance at concentrations encompassing sample concentrations are measured, and a 
calibration graph is constructed. The concentration of analyte in the sample solution 
read from the graph as concentration corresponding absorbance of the solution. 
Calibration data is essential if absorbance has nonlinear relationship with concentration 
if the absorbance values and concentrations bear a linear relationship the regression line 
then, 
Y=  α + βx may be calculated by method of least squares. 
 
Intercept (α)     =     (Σ y) (Σx2) – (Σ x) (Σ x y) 
      N Σ x2 – (Σ x) 2 
 
Slope (β)           =     N Σ x y – (Σ x) (Σ y) 
N Σ x2 – (Σ x) 2 
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Where, 
y = Absorbance value at concentration x. 
N = Number of pairs of values. 
The data may be further evaluated statistically to confirm a linear relationship 
between x and y and provides confidence limits for the slope intercept and estimated 
concentration of sample. 
SINGLE OR DOUBLE POINT STANDARDIZATION 
 The procedure involves the measurement of the absorbance of a sample solution 
and of a standard of the reference substance. The standard and the sample solution are 
prepared in similar manner; ideally the concentration of the standard solution should be 
close to that of the sample solution. The concentration of the substance in the sample is 
calculated using following formulas 
    Ctest = Atest / Astd × Cstd 
Where, 
Ctest and Cstd are the concentration of the sample and standard solutions, 
respectively. 
 Atest and Astd are the absorbance of the sample and standard solutions, 
respectively. 
In double point standardization, the concentration of one of the standard 
solutions is greater than that of the sample while the other standard solution has a lower 
concentration than the sample solution. The concentration of the substance in the 
sample solution is given by 
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(A test – A std1) (C std1-C std2) +C std1 (Astd1-Astd2) 
              C test   =           A std1-A std2 
Where, 
Cstd is the concentration of the standard solution. 
 Atest and Astd are the absorbance of the sample and standard solutions, 
respectively. Std 1 and std 2 are the more concentrated standard and less concentrated 
standard    solutions, respectively. 
 
VALIDATION OF ANALYTICAL PARAMETERS IN PHARMACEUTICAL 
ANALYSIS BY UV SPECTROPHOTOMETRY 
1. SENSITIVITY 
Knowledge of the sensitivity of the reaction is important and three methods are 
commonly employed for expressing sensitivity. 
Sandell’s sensitivity 
Number of micrograms of drug converted into the colored product is determined; 
which in a column solution of cm2/cross-section shows an absorbance of 0.001 or 0.005 
(expressed as µg of drug/cm2). 
Molar extinction co- efficient (∈) 
It is calculated from the equation 
∈   = A/IC 
Where, 
A = absorbance 
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C = Concentration of colored species (Mole/Iit) 
I = light path length (cm) 
Ringbom plots 
Optimum photometric ranges are calculated from the linear portion of the 
Ringbom plot between Percent transmission Vs Logarithm of the concentration of the 
drug (expressed as µg/ml). 
Knowledge of the above mentioned method is necessary, for comparing the sensitivity of 
the proposed and reported methods to each drug. 
 
2. CORRELATION COEFFICIENT(r) 
When the changes in one variable are associated or followed by changes in the 
other, it is called correlation. The numerical measure of correlation is called the 
coefficient of correlation and is defined by the relation. 
N ε xy  - ε x . ε y 
r =    --------------------------------------------------- 
√ (N ε x2  -  ( ε x )2 . N ε y2  -  ( ε y )2) 
 
3. REGRESSION EQUATION 
Y = mx +c 
     N ε xy  - ε x . ε y 
m = slope =    ----------------------------- 
      N ε x2  -  ( ε x )2 
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                             ε y . ε x2  - εx . ε xy 
c = Intercept =          ---------------------- 
                                  N ε x2  -  ( ε x )2 
4. PRECISION 
The precision (or reproducibility) of the proposed method was ascertained by 
analyzing the same concentration (3/4th of the upper Beer's law limit) of the drug in 
freshly prepared test solution eight times. The set of absorbance values obtained were 
then used to obtain the standard deviation, which is expressed in absorbance units or as a 
percentage of mean absorbance. 
S = √ (X- X) 2/N – 1 
Where, 
X = observed values 
X = Arithmetic mean = √X/N 
N = Number of deviations 
For practical interpretation it is more convenient to express ‘S' in terms of percent of the 
approximate average of the range of analysis is used in the calculation of 'S'. This is 
called co-efficient of variation (C.V.) or percent relative standard deviation (% R.S.D.). 
It is customary to use probability limits (P) 0.05 level (95% of the readings will be within 
the calculated limits x ± a, where a = t.s/√n, t value is 2.365 from Students table) and 
0.01 level (99% of the readings will be within the limits x ± b, where b = t.s/√n, t value 
is 3.499 from students Table for eight determinations). 
% range of error at p = 0.05 level = ± 100 a/x 
% range of error at p = 0.01 level = ± 100 a/x 
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5. ACCURACY 
The accuracy of the recommended procedure is evaluated by comparing the 
values obtained in the proposed and reported methods. 
Percent recovery studies 
Recovery studies by adding known quantities of drug to previously analyzed 
pharmaceutical preparations are followed using proposed procedure. To study percent 
recovery, fixed amount of the sample is taken in a series of volumetric flasks and three 
different levels of standard solutions are added. Each level of the added drug is repeated 
six times. The total amount of the drug is then determined by the proposed method. 
The percent recovery is calculated by using the equation: 
        N. √xy – (√x) (√y) 
% Recovery =   ------------------------------ X 100 
N √x2 – (√x) 2 
Where 
x = amount of drug added in mg/g of sample 
y = amount of drug found in mg/g of sample 
N = total number of observations 
 
6. INTERFERENCE STUDIES 
The effects of a wide range of excipients and other additives usually present in 
formulations on the determinations under optimum conditions were investigated. 
In the initial interference studies, a fixed concentration of the drug was 
determined several times by the recommended procedure in the presence of a suitable   
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(1-100 fold) molar excess of the foreign compound under investigation and its effect on 
the absorbance of solution was noted. The foreign compound was considered to be not 
interfering at these concentrations if it consistently produces an error less than 3% in the 
absorbance produced in pure solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
1.3 AREA UNDER CURVE METHOD   (Telekone et al., 2010) 
            The area under curve method is applicable where there is no sharp peak or when 
broad spectra are obtained. It involves the calculation of integrated value of absorbance 
with respect to the wavelength between the two selected wavelengths λ1 and λ2. Area 
calculation processing item calculates the area bound by the curve and the horizontal 
axis. The horizontal axis is selected by entering the wavelength range over which area 
has to be calculated. This wavelength area is selected on the basis of repeated observation 
so as to get the linearity between area under curve and concentration.  In combination 
drugs λ1 and λ2 denotes the wavelength ranges of the components. The integrated value of 
absorbance in the wavelength ranges of both the drugs are substituted in the simultaneous 
equation to get the concentration of the drugs. 
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1.4 DERIVATIVE SPECTROSCOPY 
                                    (Robert D. Braun, 2006, Beckett et al., 2007, Kenneth A Connors, 2002,) 
INTRODUCTION 
Derivative spectrophotometry is useful means of resolving two overlapping 
spectra and eliminating matrix interference due to an indistinct shoulder on side of an 
absorption bands. It involves conversion of normal spectrum [A= f (λ)] to its first [dA/ dλ 
= f (λ)], second [d2A/ dλ2 = f (λ)] and higher derivatives spectra where the amplitude in 
the derivative spectrum is proportional to the concentration of the analyte provided that 
Beer’s law is obeyed by the fundamental spectrum.  
dA/ dλ =  (dA/dt) / (dλ /dt) = (dA/dt)(1/C) 
 
A first derivative spectrum is a plot of dA/dλ or dT/dλ as a function of wavelength, and 
a second derivative spectrum is a plot of d2A/dλ2 as a function of λ. examples of instruments 
that are capable of recording derivative spectra include the Baush and Lomb spectronic 2000, 
the varian DMS 90 and DMS 100, the Gilford 2600, and Hitachi 100-80. 
First and second derivative spectra often show detail that is lacking in conventional 
spectra. That detail can be an aid in the qualitative or quantitative analysis of sample.    
    
INSTRUMENTATION                                                               (Robert D.Braun, 2006)   
Derivative spectra may be generated by any of three techniques. The earliest derivative 
spectra were obtained by modification of the optical system   spectrophotometers with dual 
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monochromators set a small wavelength interval (▲λ, typically 1-3 nm) apart, or with the 
facility to oscillate the wavelength over a small range, are required                     
TYPICAL DIAGRAM OF DERIVATIVE SPECTRA 
        (http://www.medicinescomplete.com) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In either case the photo detectors generates a signal with amplitude proportional to the 
slope of the spectrum over the wavelength interval. Instruments of this type are expensive and 
are essentially restricted to the recording of first derivative spectra only. 
28 
 
The second technique to generate derivative spectra is electronic differentiation of the 
spectrophotometers analog signal resistance capacitance (RC) modules may be incorporated in 
series between the spectrophotometer and recorder to provide differentiation of the absorbance,  
not with respect to wavelength, but with respect to time,  there  by  producing signal dA/dt. 
The third technique is based upon micro computer differentiation. micro computers 
incorporated into or interfaced with the spectrophotometer may be programmed to provide 
derivative spectra during or after the scan,  to measure derivative amplitudes between specified 
wavelengths and to calculate concentration  and associated statistics from the  measured 
amplitudes. 
DIAGRAM OF ZERO, FIRST AND SECOND ORDER SPECTRAS OF A COMPOUND 
     (Robert D.Braun, 2006) 
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1.5 VISIBLE SPECTROPHOTOMETRY 
          (B.K. Sharma, 2007, Mendham J et al., 2002) 
Visible spectrophotometry involves the measurement of the amount of visible 
radiation (400 - 800 nm) absorbed by a colour solution. Using this, the quality of an 
element present is estimated from the intensity of the colour of the solution due to the 
presence of a coloured compound of that element. The more intense colour is the higher 
concentration of the element in solution. 
Some compounds are self coloured and for other it is necessary to develop colour 
by the addition of one or more colour forming reagents (chromogenic reagents) such as 
MBTH, NED, FC etc. The absorbing capacity of a coloured system is directly 
proportional to the amount of desired constituent. 
Colorimetric analysis should satisfy following criteria. 
• The colour reaction should be specific 
• Proportionality change between colour and concentration 
• Colour should be stable to permit an accurate reading 
• Reproducible result should be notified 
• Solution must be free from precipitate 
• The colour reaction should be highly sensitive 
In physics colorimetry refers to the measurement of colour and the determination 
involves neither the nature of the colourant nor its amounts. In chemistry, a general term 
called absorptiometry is used for chemical analysis through measurement of radiation. 
Chemical systems which exhibit a selective light absorptive capacity or coloured, and 
hence the terms colorimetric analysis and colorimetry are often applied to the 
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measurements of such system when the object is to determine the concentration of the 
consistutents responsible for the colour. In other words the variation of some component 
forms the basis of colorimetric analysis and it is concerned with the determination of the 
concentration of a substance by measurement of the relative absorption of light with 
respective of a known concentration of substance. 
Colours of different wavelength                                    (kasture et al., 2007) 
Wavelength (nm) Absorbed color Transmitted color 
380-450 Violet Yellow – green 
450-495 Blue Yellow 
495-570 Green Violet 
570-590 Yellow Blue 
590-620 Orange Green – blue 
620-760 Red Blue – green 
 
Disadvantage of colorimetry  
1. These methods always require the availability of a standard or a series of 
standards. 
2. The eye will not be able to match the colour in presence of a standard colored 
substances. If present in the solution. 
3. The eye is not sensitive enough to small differences in absorbances as a 
photoelectric device. 
4. Concentration difference smaller than about 5% relative are difficult to be 
deteceted. 
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           1.6 HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY   
       (sethi P.D.,1996) 
Set the analytical objective first that may be quantification or qualitative 
identification or separation of two components/multicomponent mixtures or optimization 
of analysis time before starting HPTLC.  Method for analyzing drugs in multicomponent 
dosage forms by HPTLC demands primary knowledge about the nature of the sample, 
namely, structure, polarity, volatility, stability and the solubility parameter.   
An exact recipe for HPTLC, however, also same like HPLC cannot be provided 
because method development involves considerable trial and error procedures.  The most 
difficult problem usually is where to start, with what kind of mobile phase.  
Various process involved in HPTLC 
1. Selection of HPTLC plates and solvent. 
2. Sample preparation including prechromatogrphic derivitization. 
3. Application of sample. 
4. Development (separation) 
5. Detection including post chromatographic derivitization. 
6. Quantification. 
7. Documentation. 
Method Development for HPTLC 
1. Set your analytical objectives –qualitative identification or quantitative 
2. Separation of two components or multi component mixtures 
3. Collect information about the sample regarding structure, polarity, solubility 
     and volatility. 
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Selection and Optimization of               Selection of Stationary Phase; 
Mobile phase                                      Prewashing of Layer 
 
In situ Pre Chromatographic              Pre Conditioning /saturation of 
Derivitisation                                             Layer 
 
 
 
 
UV-Visible /Fluorescent                 post Chromatographic 
Detection                                    Derivatisation 
 
 
Plates 
Plates are classified as two types 
1. Hand made plates. 
2. Pre-coated plates. 
Mobile phase 
Poor grade of solvent used in prerparing mobile phase have found ro decrease 
resolution, spot definition and Rf  reproducibility. 
Sample Preparation 
Application of Sample 
Development of Chromatogram 
Detection of Analytes 
Quantitative Evaluation 
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Activation of precoated plates 
Plates exposed to high humidity or kept on hand for long time may have to be 
activated by placing in oven at 110-120˚C for 30 minutes. 
Sample prepation 
The sample preparation is not as demanding as for other chromatographic 
techniques, however several steps for sample pre-treatment may be necessary such as 
sampling, mechanical crushing, extraction, filtration and enrichment of minor 
compounds. Proper sample preparation is an important for success of HPTLC separation. 
Application of sample 
The sample should be applied through clean upper end of the capillary and for 
that filling to marked point, reverse the capillary for applying the sample. 
Pre-conditioning (chamber saturation) 
If the tank is saturated prior to development, solvent vapours soon get uniformly 
distributed throught the chamber. As soon as the plate is placed in such a saturated 
chamber, it soon gets pre-loaded with solvent vapours, hence less solvent shall be 
required to travel particular distance, resulting lower Rf values. 
Development and drying 
After development the plate is removed from the chamber and mobile phase is 
removed as completely and as quickly as possible. This step should preferably be 
performed infume cup board to avoid contamination of laboratory atmosphere. The plates 
should always be laid horizontally, so that while mobile phase evaporates the separated 
substances will migrate evenly to the surface where they can be easily detected. 
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Detection and visualiztiion 
Detection sensitivity depends on the reagent employed. Iodine is the universal 
detection reagent, the detection usually non-destructive and reversible but certain 
substance may be altered through non-reversible derivitization. 
Quantification 
-  Sample and standard should be chromatographed on same plate 
-  After development chromatogram is scanned 
-  Camag TLC scanner III scan the chromatogram in reflectance or in transmittance 
mode by absorbance or by fluorescent mode 
-  Scanning speed is selectable up to 100 mm/s 
-  Spectra recording are fast - 36 tracks with up to 100 peak windows can be 
evaluated 
-  Calibration of single and multiple levels with linear or non-linear regressions are 
possible when target values are to be verified such as stability testing and dissolution 
profile single level calibration is suitable 
-  Statistics such as RSD or CI report automatically 
-  Concentration of analyte in the sample is calculated by considering the sample 
initially taken and dilution factors. 
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1.7 VALIDATION OF ANALYTICAL METHOD                                                      
(Code Q2A, 1994; Code Q2B, 1996; ICH Guidelines) 
Validation is an act of proving that any procedure, process, equipment, material, 
activity or system performs as expected under given set of conditions and also give the 
required accuracy, precision, sensitivity, ruggedness, etc. 
When extended to an analytical procedure, depending upon the application, it means that 
a method works reproducibly, when carried out by same or different persons, in same or 
different laboratories, using different reagents, different equipments, etc. 
The objective of the analytical procedure should be clearly understood since this will 
govern the validation characteristics which need to be evaluated.  Typical validation 
characteristics which should be considered are listed below 
1. Accuracy 
2. Precision(Repeatability and Reproducibility), 
3. Linearity and range 
4. Limit of detection (LOD)/ limit of quantization (LOQ), 
5. Selectivity/ specificity 
6. Robustness/ ruggedness and 
7. Stability and system suitability studies 
 
Advantages of Analytical method Validation: 
The biggest advantage of method validation is that it builds a degree of 
confidence, not only for the developer but also to the user. 
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Although the validation exercise may appear costly and time consuming, it results 
inexpensive, eliminates frustrating repetitions and leads to better time management in the 
end. Minor changes in the conditions such as reagent supplier or grade, analytical setup 
are unavoidable due to obvious reasons but the method validation absorbs the shock of 
such conditions and pays for more than invested on the process. 
 
ANALYTICAL METHOD VALIDATION: 
Key Parameters of the Analytical Method Validation:- 
It is important for one to understand the parameters or characteristics involved in 
the validation process. The various Performance parameters, which are addressed in a 
validation exercise, are grouped as follows. 
(1) Accuracy: - 
The accuracy of an analytical method may be defined as the closeness of the test 
results obtained by the method to the true value. It is the measure of the exactness of the 
analytical method developed. Accuracy may often express as percent recovery by the 
assay of a known amount of analyte added. 
Accuracy may be determined by applying the method to samples or mixtures of 
excipients to which known amount of analyte have been added both above and below the 
normal levels expected in the samples. Accuracy is then calculated from the test results as 
the percentage of the analyte recovered by the assay. Dosage form assays commonly 
provide accuracy within 3-5% of the true value. 
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(2) Precision: - 
The precision of an analytical method is the degree of agreement among 
individual test results when the method is applied repeatedly to multiple samplings of 
homogenous samples. This is usually expressed as the standard deviation or the relative 
standard deviation (coefficient of variation). Precision is a measure of the degree of 
reproducibility or of the repeatability of the analytical method under normal operating 
circumstances. 
Repeatability involves analysis of replicates by the analyst using the same equipment 
and method and conducting the precision study over short period of time while 
reproducibility involves precision study at 
• Different Occasions, 
• Different Laboratories, 
• Different Batch of Reagent, 
• Different Analysts, 
• Different Equipments. 
Determination of Repeatability: 
It defined as the precision of the procedure when repeated by same analyst under 
the same operating conditions (same reagents, equipments, settings and laboratory) over a 
short interval of time. It is normally expected that at least six replicates be carried out and 
a table showing each individual result provided from which the mean, standard deviation 
and co-efficient of variation should be calculated for set of n value. The RSD values are 
important for showing degree of variation expected when the analytical procedure is 
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repeated several time in a standard situation. (RSD below 1% for built drugs, RSD below 
2% for assays in finished product). 
Determination of reproducibility: 
It means the precision of the procedure when it is carried out under different 
conditions-usually in different laboratories-on separate, putatively identical samples 
taken from the same homogenous batch of material. Comparisons of results obtained by 
different analysts, by the use of different equipments, or by carrying out the analysis at 
different times can also provide valuable information. 
(3) Linearity and range: 
The linearity of an analytical method is its ability to elicit test results that are 
directly (or by a well defined mathematical transformation) proportional to the analyte 
concentration in samples within a given range. Linearity usually expressed in terms of the 
variance around the slope of regression line calculated according to an established 
mathematical relationship from test results obtained by the analysis of samples with 
varying concentrations of analyte. 
The linear range of detect ability that obeys Beer’s law is dependent on the 
compound analyzed and the detector used. The working sample concentration and 
samples tested for accuracy should be in the linear range. The claim that the method is 
linear is to be justified with additional mention of zero intercept by processing data by 
linear least square regression. Data is processed by linear least square regression 
declaring the regression co-efficient and b of the linear equation y= ax + b together with 
the correlation coefficient of determination r. For the method to be linear the r value 
should be close to1. 
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The range of an analytical method is the interval between the upper and lower 
levels of the analyte (including these levels) that have been demonstrated to be 
determined with precision, accuracy and linearity using the method as written. 
(4) Limit of Detection and limit of Quantitation: 
Limit of detection: 
The limit of detection is the parameter of limit tests. It is the lowest level of 
analyte that can be detected, but not necessarily determined in a quantitative fashion, 
using a specific method under the required experimental conditions. The limit test thus 
merely substantiates that the analyte concentration is above or below a certain level. 
The determination of the limit of detection of instrumental procedures is carried out by 
determining the signal-to-noise ratio by comparing test results from the samples with 
known concentration of analyte with those of blank samples and establishing the 
minimum level at which the analyte can be reliably detected. A signal-to-noise ratio of 
2:1 or 3:1 is generally accepted. 
The signal-to-noise ratio is determined by dividing the base peak by the standard 
deviation of all data points below a set threshold. Limit of detection is calculated by 
taking the concentration of the peak of interest divided by three times the signal-to-noise 
ratio. 
For spectroscopic techniques or other methods that rely upon a calibration curve 
for quantitative measurements, the IUPAC approach employs the standard deviation of 
the intercept (Sa) which may be related to LOD and the slope of the calibration curve, b, 
by 
LOD = 3 Sa / b 
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Limit of quantitation:- 
Limit of quantitation is a parameter of quantitative assays for low levels of 
compounds in sample matrices such as impurities in bulk drugs and degradation products 
in finished pharmaceuticals. The limit of quantitation is the lowest concentration of 
analyte in a sample that may be determined with acceptable accuracy and precision when 
the required procedure is applied. 
It is measured by analyzing samples containing known quantities of the analyte and 
determining the lowest level at which acceptable degrees of accuracy and precision are 
attainable where the final assessment is based on an instrumental reading, the magnitude 
of background response by analyzing a number of blank samples and calculating the 
standard deviation of this response. The standard deviation multiplied by a factor (usually 
10) provides an estimate of the limit of quantitation. In many cases, the limit of 
quantitation is approximately twice the limit of detection. 
5) Selectivity and Specificity:- 
The selectivity of an analytical method is its ability to measure accurately and 
specifically the analyte of interest in the presence of components that may be expected to 
be present in the sample matrix. 
If an analytical procedure is able to separate and resolve the various components 
of a mixture and detect the analyte qualitatively the method is called selective. On the 
other hand, if the method determines or measures quantitatively the component of interest 
in the sample matrix without separation, it is said to be specific. 
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Hence one basic difference in the selectivity and specificity is that, while the former is 
restricted to qualitative detection of the components of a sample, the latter means 
quantitative measurement of one or more analyte. 
Selectivity may be expressed in terms of the bias of the assay results obtained 
when the procedure is applied to the analyte in the presence of expected levels of other 
components, compared the results obtained when the procedure is applied to the analyte 
in the presence of expected levels of other components, compared to the results obtained 
on the same analyte without added substances. When the other components are all known 
and available, selectivity may be determined by comparing the test results obtained on the 
analyte with and without the addition of the potentially interfering materials. When such 
components are either unidentified or unavailable, a measure of selectivity can often be 
obtained by determining the recovery of a standard addition of pure analyte to a material 
containing a constant level of the other components. 
(6) Robustness and Ruggedness:- 
 Robustness: 
It is an analytical method is a measure of its capacity to remain unaffected by 
small but deliberate variation in method parameters and provides an indication of its 
reliability during normal usage. The determination of robustness requires that 
methods characteristic are assessed when one or more operating parameter varied. 
 Ruggedness: 
It is an analytical method is the degree of reproducibility of test results obtained  
by the analysis of the same samples under a variety of normal test  conditions such as 
different laboratories, different analysts, using operational and environmental 
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conditions that may differ but are still within the specified parameters of the assay. 
The testing of ruggedness is normally suggested when the method is to be used in 
more than one laboratory. Ruggedness is normally expressed as the lack of the 
influence on the test results of operational and environmental variables of the 
analytical method. 
For the determination of ruggedness, the degree of reproducibility of test 
result   is determined as function of the assay variable. This reproducibility may be 
compared to the precision of the assay under normal condition to obtain a measure of 
the ruggedness of the analytical method. 
(7) Stability and System suitability tests:- 
Stability of the sample, standard and reagents is required for a reasonable time to 
generate reproducible and reliable results. For example, 24 hour stability is desired for 
solutions and reagents that need to be prepared for each analysis. 
System suitability test provide the added assurance that on a specific occasion the 
method is giving, accurate and precise results. System suitability test are run every time a 
method is used either before or during analysis. The results of each system suitability test 
are compared with defined acceptance criteria and if they pass, the method is deemed 
satisfactory on that occasion. The nature of the test and the acceptance criteria will be 
based upon data generated during method development optimization and validation 
experiments. 
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1.8 PHARMACEUTICAL STATISTICS (Kenneth, 2002, Sundar Rao P.S et al, 2006)             
Statistical techniques have been widely used in many diverse areas of scientific 
investigation. Statistical applications have been recognized as crucial to quality control 
procedure, test, specification and definitions. Principle of modern analytical techniques 
and skill in their application are necessary attribute of the successful pharmaceutical 
analyst, thus does not ensure the satisfactory solution of all the problem that may 
encountered. Some auxiliary knowledge methods those can aid the analyst in designing 
experiment, collecting data, and interpreting the result. 
1.8.1. Linear regression 
          Linear regression a statistical technique that defines the functional relationship 
between two variables by best-fitting straight line.  Once a linear relationship has been 
shown to have a high probability by the value of the correlation coefficient ‘r’, then the 
best straight line through the data points has to be estimated. This can often be done be 
done by visual inspection of the calibration graph, but in many cases it is far more 
sensible to evaluate the best straight line by linear regression (the method of least 
squares) 
The equation of straight line is  
y = mx + c 
Where, y the dependent variable is plotted as result of changing x, the independent 
variable. 
         To obtain the regression line ‘y on x’ the slope ‘m’ of the line and the intercept ‘c’ 
on the y axis are given by the following equation. 
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                        N Σxy – (Σx) (Σy)  
 m = 
                            N Σx2 – (Σx)2 
and           
          (Σy) (Σx2) – (Σx) (Σxy) 
 c =  
                                   N Σx2 – (Σx)2 
1.8.2. Correlation coefficient (r) 
         It is a procedure commonly used to characterize quantitatively the relationship 
between variable. Correlation is related to linear regression.  To establish whether there is 
a linear relationship between two variables x1 and y1, use Pearson’s correlation 
coefficient r. 
                   n Σx1y1 - Σx1y1  
         r =  
      {[n Σx12 – (Σx1)2] [n Σy12 – (Σy1)2]}1/2 
  Where n is the number of data points. 
  The value of r must lie between +1 and -1, the nearer it is to +1, the greater the 
probability that a definite linear relationship exists between the variables x and y, values 
close to +1 indicate positive correlation and values close to -1 indicate negative 
correlation values of ‘r’ that tend towards zero indicate that x and y are not linearly 
related (they made be related in a non-linear fashion). 
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1.8.3. Standard deviation (SD) 
          It is commonly used in statistics as a measure of precision statistics as a measure 
of precision and is more meaningful than is the average deviation. It maybe thought of 
as a root-mean-square deviation of values from their average and is expressed 
mathematically as 
( )
1N
xx
S
ni
1i
i
−
−
=
∑=
=  
Where, 
S is standard deviation. 
If N is large (50 or more) then of course it is immaterial whether the term in the 
denomination is N -1 or N  
Σ       = sum 
x      = Mean or arithmetic average. 
x -x  = deviation of a value from the mean 
N      = Number of observations 
 1.8.4. Percentage relative standard deviation (%RSD) 
          It is also known as coefficient of variation (CV). It is defined as the standard 
deviation (S.D) expressed as the percentage of mean. 
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     C 100
x
S.DRSD  %or  V ×=  
Where,  
S.D is the standard deviation, 
x      = Mean or arithmetic average. 
 The variance is defined as S2 and is more important in statistics than S itself.  
However, the latter is much more commonly used with chemical data. 
1.8.5. Standard error of mean (SE) 
 Standard error of mean can be defined as the value obtained by division of 
standard deviation by square root of number of observations. It is mathematically 
expressed as  
    n
S.D.S.E. =    
Where, 
 S.D = Standard deviation 
         n = number of observations. 
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2. REVIEW OF LITERATURE 
DRUG PROFILE     (http://en.wikipedia.org/wiki/Dapoxetine.) 
DAPOXETINE   
MOLECULAR STRUCTURE 
 
 
 
CHEMICAL STRUCTURE 
N,N-dimethyl-3-(naphthalene-1-yloxy)-1-phenylpropan-1-amine 
MOLECULAR FORMULA  
C21H23NO 
MOLECULAR WEIGHT  
Dapoxetine 341.88g/mol 
DESCRIPTION  
White to off white powder 
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STORAGE AND STABILITY 
Store at room temperature, protected from light and moisture. Keep out of  
children. 
SOLUBILITY 
Soluble in water at 10mg/mL as a free base (pH dependent) 
IDENTIFICATION  
1. Melting point 
Drug Standard value Observed value* 
Dapoxetine 175-180˚C 175.1 
* average of six determination. 
2. IR spectra was recorded and shown in figure 1. 
INDICATION  
Dapoxetine is indicated for the treatment of premature ejaculation (PE) in men 18 
to 64 years of age. 
PHARMACODYNAMICS  
Dapoxetine is a selective serotonin reuptake inhibitor. Ejaculation is controlled by 
both serotonin and dopamine: primarily the 5-HT2c and 5-HT1a receptors. It works by 
inhibiting the reuptake of the serotonin transporter. It also bind to and inhibits the 
reuptake transporters of dopamine and nor epinephrine. 
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PHARMACOKINETICS  
A randomized, double-blind, placebo-controlled trial of 77 healthy male 
volunteers was used to assess the pharmacokinetics of Dapoxetine, using a single dose 
(60, 100, 140, or 160 mg) or multiple doses (60, 100, 140, or 160 mg) of Dapoxetine over 
a 6 day period. Dapoxetine was rapidly absorbed after being taken by mouth, with a peak 
plasma concentration between 1.4 and 2.0 hours. This was immediately followed by a 
rapid decline in plasma concentration, to about 5% of peak concentration within 24 
hours. 
Distribution 
Reported evidence suggests that Dapoxetine is rapidly more than 99% of 
Dapoxetine is bound to human serum proteins. The active metabolite 
DesMethylDapoxetine (DED) is 98.5% protein bound. Dapoxetine appears to have a 
rapid distribution with a mean steady state volume of distribution of 162 L, following 
values for Dapoxetine were 0, 10, 2, 19 and 19.3 respectively. 
Metabolism 
The metabolism of Dapoxetine was extensively metabolized to multiple 
metabolites primarly through the following biotransformational pathways: N-oxidation, 
N- demethylation, napthyl hydroxylation, glucuronidation and sulfation. There was 
evidence of presynaptic first pass metabolism after oral administration 
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Elimination 
The metabolite of Dapoxetine were primarily eliminated in the urine as 
conjugates. Unchanged active substance was not detected in the urine. Dapoxetine has a 
rapid elimination, as evidence by a low concentration (less than 5%  of peak) 24 hours 
after dosing. There was minimal elimination of Dapoxetine following daily dosing. The 
terminal half life is approximately 19 hours following oral administration.  
DOSAGE AND ADMINISTRATION  
The recommended dose for Dapoxetine is 30mg, taken as needed approximately 1 
to 3 hour prior to sexual activity. The maximum recommended dosing  frequency is once 
every 24 hours. If the effect of 30mg is insufficient and the side effects are acceptable, 
the dose may be increased to the maximum recommended dose of 60mg. 
Tablets should be swallowed whole to avoid the bitter taste. It is recommended 
that tablets be taken with at least one full glass of water. 
SIDE EFFECTS 
Dapoxetine is the only approved medication to treat premature 
ejaculation. Dapoxetine is well tolerated with very few side effects, the most common 
side effects: headache, dizziness, nausea or diarrhoea. In case having side effects is not 
for long term. Dapoxetine is absorbed in body and leaves the body quite quick. 
Dapoxetine have successfully improved premature ejaculation, including reduction of 
personal distress and improvement in the satisfaction with the sexual intercourse.  
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DRUG INTERACTIONS 
There are no known drug interactions known to be associated with Dapoxetine at 
this time. According to published studies, Dapoxetine can be safely taken with the 
phosphodiesterase (PDE5) inhibitors tadalafil (Cialis) and sildenafil (Viagra). 
In patients receiving an SRRI in combination with a monoamine oxidase inhibitor 
(MAOI), there have been reports of serious, sometimes fatal, reactions including 
hyperthermia, rigidity, myoclonus, autonomic instability with rapid fluctuations of vital 
signs and coma. 
As with other SSRIs, co-administration with serotonergic medicinal /herbal 
products may lead to an incidence of serotonin associated effects. 
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2.2 REPORTED METHODS 
 
2.2.1 Mehtal Pratik et al., (2011) reported “Development and validation of a RP-HPLC 
method for the determination of Dapoxetine Hydrochloride in pharmaceutical 
formulation using an experimental design”. 
A rapid and sensitive RP-HPLC method with UV detection (230 nm) for 
routine analysis of Dapoxetine HCl in a pharmaceutical formulation (Priligy) was 
developed. Chromatography was performed with mobile phase containing a mixture 
of buffer [Tri-ethyl amine, pH-4.0 (adjusted with o-phosphoric acid)] and acetonitrile 
(60:40, v/v) with flow rate was 1.0ml min-1. The procedure was validated for 
linearity (correlation coefficient=0.9998), accuracy, robustness and intermediated 
precision. The R.S.D.value (0.5%, n=6) indicated a good precision of the analytical 
method. The proposed method was simple, highly sensitive, precise and accurate and 
retention time less than 5min indicating that the method is useful for routine quality 
control. 
2.2.2 Thyseen AN et al., (2010) reported “Pharmcokinetics of Dapoxetine 
Hydrochloride in Healthy Chinese, Japanese, and Caucasian Men”. 
  Dapoxetine is the first oral medication specifically developed for the on-
demand treatment of premature ejaculation. Premature ejaculation is a sexual 
dysfunction characterized by an inability to control ejaculation, a short intravaginal 
ejaculatory latency time, and the consequential negative impact of the condition such 
as low satisfaction with sexual intercourse, distress, and interpersonal difficulty. 
Dapoxetine is approved in some European Union countries, as well as Mexico and 
Korea, for the treatment of premature ejaculation.  
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3. AIM AND PLAN OF WORK 
3.1 Aim of work 
Most of the pharmaceutical industries are manufacture new drug formulations to 
meet the market requirement. The survey of the Dapoxetine is chemically (S)-N,N-
dimethyl-3-(naphthalene-1-yloxy)-1-phenylpropan-1-amine. The Dapoxetine is launched 
and indicated for the treatment of premature ejaculation (PE). 
The literature review revealed that there are only few methods reported for 
quantitative analysis of Dapoxetine in HPLC method. But there is no spectrophotometric 
method was reported for the estimation of Dapoxetine in tablet dosage form. Plan was 
targeted to presume the present research project work by selecting Dapoxetine as drug. 
3.2 Plan of work 
 3.2.1 Survey of the literature  
From the survey of the literature for Dapoxetine, their physical properties, 
chemical properties, pharmacological and pharmacokinetic studies details were collected 
for the development of several analytical methods. 
3.2.2 Procurement of drug sample 
 The Dapoxetine was obtained as gift sample Alkem Laboratories. The 
commercial formulation was procured from local pharmacy. 
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3.2.3 Validation of developed methods 
 All the methods, which have been developed and validated according to ICH 
guidelines. 
 Therefore in the proposed research project a successful effort has been made to 
develop simple economic accurate and rapid methods for the estimation of Dapoxetine in 
bulk and in tablet dosage formulation and validated all the methods as per ICH 
guidelines. 
The methods are  
  UV Spectrophotometric Method  
  Area Under Curve Method 
Derivative Spectrophotometric Method 
  Visible Spectrophotometric Method 
  High Performance Thin Liquid Chromatography 
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4. MATERIALS AND METHODS 
4.1 MATERIALS 
4.1.1 Drug Samples (Raw material) 
               Dapoxetine was obtained as a gift sample from Alkem Laboratories, Hyderabad. 
4.1.2 Formulation used 
              PRILYXET tablets (Sun pharma sikkim, East sikkim) containing Dapoxetine 30 
mg was procured from Medplus pharmacy, Chennai.                   
4.1.3 Chemicals and solvents used 
             Distilled water, MBTH reagent (AR Grade), Cerric Ammonium Sulphate (AR 
Grade), Methanol (HPLC grade), Water (HPLC grade), were purchased from Qualigens 
India Pvt. Limited and Loba Chemie India Limited, Mumbai. 
4.1.4 Instruments used 
  Different instruments used to carry out the present work, 
1) Shimadzu AUX - 220 Digital balance 
2) Shimadzu - 1700 Double Beam UV - Visible spectrophotometer with pair of 10 
mm matched quartz cells 
3) ELICO SL - 210 Double Beam UV - Visible spectrophotometer with pair of      10 
mm matched quartz cells 
4) ELICO pH meter (Model LI - 120) 
5) Sonicator – Sonica ultrasonic cleaner – Model 2200 MH 
6) REMI – Centrifuge apparatus 
7) CYBERLAB – Micropipette 
8) SUNBIM – Melting point apparatus          
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Specifications (Terms) of instruments 
a) Shimadzu AUX - 220 Digital balance (Shimadzu Instruction Manual) 
 
                                        Specifications 
     Weighing capacity 200 gms 
     Minimum display 0.1 mg 
     Standard deviation ≤ 0.1 mg 
     Operation temperature range 5 to 40° C 
 
b) Double Beam UV - Visible Spectrophotometer (Shimadzu and ELICO Instruction 
Manual) 
 Model: Shimadzu UV - 1700; Double beam UV - Visible spectrophotometer. 
ELICO SL – 210; Double beam UV - Visible spectrophotometer. 
Specification Shimadzu UV - 1700 Elico SL - 210 
Light source 
20 W halogen lamp, 
Deuterium lamp,  
Light source position 
automatic adjustment 
mechanism. Built in lamp 
lighting time display 
function. 
Tungsten halogen lamp (W), 
Deuterium lamp (D), 
 Light source position 
automatic adjustment 
mechanism. 
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Monochromator  
Aberration- correcting 
concave blazed holographic 
grating 
Concave holographic grating 
with 1200 lines/ mm 
Detector Silicon photodiode Photodiode 
Stray Light 
0.04% or less (220 nm; NAI 
10g/ lt) 
0.04% or less (340 nm; 
NaNo2 50g/ lt). 
< 0.05% T at 220 nm with 
NAI  10g/ lt 
Measurement  
Wavelength range 190 ~ 1100 nm 190 ~1100 nm 
Spectral Band width 1 nm or less (190 to 900nm). 1.8 nm 
Wave length Accuracy 
± 0.5 nm on broad automatic 
wavelength calibration 
mechanism. 
± 0.5 nm automatic 
wavelength calibration 
mechanism. 
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Recording range 
Absorbance - 3.99 ~ 3.99 Abs 
Transmittance;                          
- 399 ~ 399% 
Absorbance; ± 3.000 Abs 
 
Photometric accuracy ± 0.004 Abs (at 1.0 Abs). ± 0.002 Abs (at 0.5 Abs). 
± 0.005 Abs (at 1.0 Abs). 
± 0.010 Abs (at 0.5 Abs). 
Operating  
Temperature/ 
Humidity 
 
Temperature range; 15 to 
35˚C 
Humidity range; 
35 to 80%(15 to below 35˚C) 
35 to 70%(30 to below 35˚C) 
 
Temperature range; 15 to 
35˚C 
Humidity range; 
35 to 80%(15 to below 35˚C) 
35 to 70%(30 to below 35˚C) 
 
4.2 HPTLC 
4.2.1 Instrument specification 
4.2.2 Stationary phase 
 Plate size (x×y) - 20×10 cm 
 Material   - HPTLC plates silica gel 60 F 254 
 Pre washing  - No 
 Modification   - No 
4.2.3 Sample application – CAMAG Automatic 4 
 Instrument   - CAMAG Automatic TLC sampler 4 (ATS4) 
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4.2.4 ATS 4 application parameters 
 Spray gas  - Nitrogen 
 Sample solvent type - Methanol 
 Rinsing solvent - Unheated  
 Rack in use  - standard 
4.2.5 Sequence  
 Syringe size  - 100 µL 
 Application type - Band 
 Band length  - 8.0 mm 
4.2.6 Development – glass tank  
 Chamber type  - twin trough chamber 20×10 cm  
 Pre-conditioning 
 Mobile phase  - Acetonitrile : Ethyl acetate (9 : 1) 
 Solvent front position - 50.0 nm 
 Volume  - 10.0 mL 
 Drying device  - Hair dryer 
 Time    - 5 minutes 
 60 
 
4.2.7 Detection – CAMAG TLC SCANNER 3 
4.2.8 Instrument – CAMAG TLC scanner 3’’ scanner 3_ 140703’’ 
 Position of first tract X - 15.0 mm 
 Distance between tracks - 10.5 mm 
 Scan start position Y  - 10.0 mm 
 Scan end position Y  - 80.0 mm 
 Optimize optical system - Light  
 Scanning speed   - 20 mm/s 
 Data resolution  - 100 µm/step 
4.2.9 Measurement table 
 Wave length   - 292 nm 
 Lamp     - D2&w 
 Measurement type  - Remission 
 Measurement mode  - Absorption 
 Optical filter   - Secound order 
 Dectector mode  - Automatic  
 PM high voltage  - 347 V 
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4.2.10 Integration 
 Data filtering   - Savitsy-golay 7 
 Base line correction   - Lowest slope 
 Peak threshold min.slope - 5 
 Peak threshold min.height - 10AU 
 Peak threshold min.area - 50 
 Peak threshold max.height - 990AU 
 Track start position  - 46.5 
 Track end position  - 56.9  
 Display scaling  - Automatic (53) 
4.2.11 Reagent and chemicals 
 Methanol gradient HPLC grade 
 Chloroform HPLC grade 
 Ethyl acetate HPLC grade 
 Silica gel GF 254 pre coated plates 
 Active pharmaceutical ingredients and formulation 
METHODS
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4.2 METHODS 
The estimation of Dapoxetine was done by following methods 
4.2.1 UV spectrophotometric method 
4.2.2 Area under curve method 
4.2.3 Derivative spectrophotometric method 
4.2.4 Visible spectrophotometric method 
4.2.5 HPTLC method. 
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4.2.1 UV SPECTROPHOTOMETRIC METHOD 
4.2.1.1 Selection of solvent  
 The solubility of Dapoxetine was determined by using variety of solvents. 
Solubility study for Dapoxetine was carried out in polar and non polar solvents. The drug 
was found to be soluble in distilled water. Considering the economic factor, distilled 
water was selected as the solvent for further analysis. 
4.2.1.2 Preparation of standard stock solution  
 10mg of Dapoxetine  working standard was accurately weighed and transferred 
into a 10 mL of volumetric flask and dissolved in minimum quantity of distilled water 
and made upto 10mL distilled water. The solution was observed to contain 1000 µg/mL 
of Dapoxetine. 
4.2.1.3 Selection of λmax  
 The standard stock solution was diluted with distilled water to get a concentration 
of 10 µg/mL of Dapoxetine. The solution was scanned between 200 and 400 nm range 
using distilled water as blank. From the UV spectra obtained, 292nm was selected as 
λmax found to be stable for 4 hours and 30 minutes. 
4.2.1.4 Preparation of working standard solution 
An accurately weighed quantity of Dapoxetine (10mg) was dissolved in 
appropriate quantity of distilled water and transferred in a 100 mL volumetric flask, and 
then volume was made up with distilled water up to the mark to get 100µg/mL.               
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A standard stock solution was further diluted in a 10 mL volumetric flask with distilled 
water to get final solution of concentration 10 µg/mL. 
4.2.1.5 Linearity and calibration graph 
 To series of six 10mL volumetric flask, different aliquots (0.5 to 3 ml) were taken 
from the above working standard solution to prepare a serious of concentration range 
from (5-30 µg/mL) using distilled water. Calibration curve was prepared at λmax 292 nm 
against water as blank in the concentration range from 5 to 30 µg/mL. 
4.2.1.6 Quantification in formulation 
 Twenty tablets were weighed accurately and triturated to fine powder. The 
powder equivalent to 25mg Dapoxetine was weighed and transferred to 25ml volumetric 
flask. Dissolved with distilled water and sonicated for 15 minutes. The solution was made 
upto 25ml with distilled water filtered through Whatmann filter paper No.41 and pipette 
out 7.5ml and make up to 50ml with distilled water from that 1ml was pippeted out and 
made up to 10ml standard flask to get the concentration of 15µg/mL. The absorbance was 
measured at 292 nm against distilled water as blank. The absorbance measurements were 
made six times for formulation. The amount of Dapoxetine present in formulation was 
calculated from the slope and intercept of respective calibration curve. 
4.2.1.7 Recovery studies 
 To determine the accuracy of the method, recovery study was performed by 
standard addition method. The recovery experiment was done by adding known 
concentration of Dapoxetine working standard to the pre-analyzed formulation. To the 
65 
 
50% of pre-analyzed tablet powder equivalent to 25mg (Label claim of tablet), known 
quantities of standard drug (80, 100 and 120 % of quantification concentration) were 
added, dissolved with distilled water and made up to volume with distilled water. The 
solutions were sonicated for 15 minutes. After sonication the solutions were filtered 
through Whatmann filter paper No 41. The absorbance of the resulting solutions were 
measured at 292nm against distilled water as blank and the amount of drug recovered 
from the formulation was calculated by using slope and intercept values. The procedure 
was repeated for three times at each level.  
4.2.1.8 Limit of Detection (LOD) and Limit of Quantification (LOQ) 
 The calibration graph was prepared from the serial dilution of the standard 
solutions were repeated for six times. The Limit of Detection and Limit of Quantification 
were calculated by using the average of slope and of intercept values. 
4.2.1.9 Ruggedness  
 Ruggedness of the method was performed by precision analysis of formulation 
was done, 
1. By using different analysts. 
2. By using different instruments. 
The Amount, SD, %RSD and Standard Error was calculated. 
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4.2.2 AREA UNDER CURVE METHOD 
4.2.2.1 Selection of solvent  
 The solubility of Dapoxetine was determined by using variety of solvents. 
Solubility studies for Dapoxetine were carried out in polar and non polar solvents. The 
drug was found to be soluble in distilled water. Considering the economic factor, distilled 
water was selected as the solvent for further analysis. 
4.2.2.2 Preparation of standard stock solution  
 10mg of Dapoxetine  working standard was accurately weighed and transferred 
into a 10 mL of volumetric flask and dissolved in minimum quality of distilled water and 
made upto 10mL distilled water. The solution was observed to contain 1000 µg/mL of 
Dapoxetine. 
4.2.2.3 Selection of λmax  
 The standard stock solution was diluted with distilled water to get a concentration 
of 10 µg/mL of Dapoxetine. The solution was scanned between 200 and 400 nm range 
using distilled water as blank. From the UV spectra obtained, Area under curve was 
calculated between 281.5 nm to 295.5 nm and found to be stable for 4 hours and 30 
minutes. 
4.2.2.4 Preparation of working standard solution 
An accurately weighed quantity of Dapoxetine (10mg) was dissolved in 
appropriate quantity of distilled water and transferred in a 100 mL volumetric flask, and 
then volume was made up with distilled water up to the mark to get 100 µg/mL.              
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A standard stock solution was further diluted to 10 mL volumetric flask with distilled 
water to get final solution of concentration 10 µg/mL. 
4.2.2.5 Linearity and calibration graph 
 To series of six 10mL volumetric flask, different aliquots (0.5 to 3 ml) were taken 
from the above working standard solution to prepare a serious of concentration range 
from (5-30 µg/mL) using distilled water. The area absorbance were scanned at a 
wavelength of 281.5 nm - 295.5 nm against distilled water as blank. The calibration curve 
was plotted between concentration and absorbance in the concentration range from          
5 to 30 µg/mL and it obeyed Beer’s law. 
4.2.2.6 Quantification in formulation 
 Twenty tablets were weighed accurately and triturated to fine powder. The 
powder equivalent to 25mg Dapoxetine was weighed and transferred to 25ml volumetric 
flask. Dissolved with distilled water and sonicated for 15 minutes. The solution was made 
upto 25ml with distilled water filtered through Whatmann filter paper No.41and from the 
above solution pipette out 7.5ml and made up to 50ml with distilled water from that 1ml 
was pippeted out and made up to 10ml standard flask to get the concentration of 
15µg/mL. The absorbance was measured between 281.5 nm - 295.5 nm against distilled 
water as blank. The absorbance measurements were made six times for formulation. The 
amount of Dapoxetine present in formulation was calculated from the slope and intercept 
of respective calibration curve. 
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4.2.2.7 Recovery studies 
 To determine the accuracy of the method, recovery study was performed by 
standard addition method. The recovery analysis was done by adding known 
concentration of Dapoxetine working standard to the pre analyzed formulation. To the 
50% of pre-analyzed tablet powder equivalent to 25mg (labeled claim of tablet), known 
quantities of standard drug (80,100 and 120 % of quantification concentration) were 
added, dissolved with distilled water and made up to volume with distilled water. The 
solutions were sonicated for 15 minutes. After sonication the solutions were filtered 
through Whatmann filter paper No 41. The absorbance of the resulting solutions were 
measured between 281.5 nm - 295.5 nm against distilled water as blank and the amount 
of drug recovered from the formulation was calculated by using slope and intercept 
values. The procedure was repeated for three times at each level.  
4.2.2.8 Limit of Detection (LOD) and Limit of Quantification (LOQ) 
 The calibration graph was prepared from the serial dilution of the standard 
solutions were repeated for six times. The Limit of Detection and Limit of Quantification 
were calculated by using the average of slope and of intercept values. 
4.2.2.9 Ruggedness  
 Ruggedness of the method was performed by precision analysis of formulation 
was done, 
1. By using different analysts. 
2. By using different instruments. 
The Amount, SD,%RSD and Standard Error was calculated. 
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4.2.3 DERIVATIVE SPECTROPHOTOMETRIC METHOD 
4.2.3.1 Selection of solvent 
 From the solubility studies of Dapoxetine, distilled water was selected as a 
solvent for Derivative spectrophotometric method, by derivatising the zero order spectra 
to a second order derivative spectrum, showed the maxima 241.0 nm and               
minima 234.5 nm respectively. 
4.2.3.2 Preparation of standard stock solution  
 10mg of Dapoxetine  working standard was accurately weighed and transferred 
into a 10 mL of volumetric flask and dissolved in minimum quantity of distilled water 
and made upto 10mL distilledwater. The solution was observed to contain 1000 µg/mL  
of Dapoxetine. 
4.2.3.3 Selection of λmax  
 The standard stock solution was diluted with distilled water to get a concentration 
of 10 µg/mL of Dapoxetine. The solution was scanned between 200 and 400 nm range 
using distilled water as blank. The zero order spectrum was derivatised to zero order 
spectrum with maxima 241.0 nm and minima 234.5nm respectively. The absorbances of 
same solution were measured repeatedly for stability study. From the stability studies, 
Dapoxetine in water was found to be stable for 4 hours and 30 minutes. 
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4.2.3.4 Preparation of working standard solution 
An accurately weighed quantity of   Dapoxetine (10mg) was dissolved in 
appropriate quantity of distilled water and transferred in a 100 mL volumetric flask, and 
then volume was made up with distilled water up to the mark to get 100 µg/mL. A 
standard stock solution was further diluted with distilled water to get final concentration 
10 µg/mL. 
4.2.3.5 Linearity and calibration graph 
 To series of six 10mL volumetric flask, different aliquots (0.5 to 3 ml) were taken 
from the above working standard solution to prepare a serious of concentration range 
from (5-30 µg/mL) using distilled water. Calibration curve was prepared at 234.5 nm and 
241.0 nm against water as blank. The calibration curve was plotted between 
concentration versus absorbance in the concentration range from 5 to 30 µg/mL. 
4.2.3.6 Quantification in formulation 
 Twenty tablets were weighed accurately and triturated to fine powder. The 
powder equivalent to 25mg Dapoxetine was weighed and transferred to 25ml volumetric 
flask. Dissolved with distilled water and sonicated for 15 minutes. The solution was made 
upto 25ml with distilled water filtered through whatmann filter paper no.41and from the 
above solution pipetted out 7.5ml and made up to 50ml with distilled water from that 1ml 
was pipetted out and made up to 10ml standard flask to get the concentration of 
15µg/mL. Then by converting the zero order spectra to second order derivative spectra, 
the absorbance measurements were made for formulation at minima 234.5 nm and 
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maxima 241.0 nm using water as blank. The amount of Dapoxetine present in 
formulation was calculated from the slope and intercept of respective calibration curve.  
4.2.3.7 Recovery studies 
 To determine the accuracy of the method, recovery study was performed by 
standard addition method. The recovery experiment was done by adding known 
concentration of Dapoxetine working standard to the pre analyzed formulation. To the 
50% of pre analyzed tablet powder equivalent to 25mg (labeled claim of tablet), known 
quantities of standard drug (80,100 and 120 %) of quantification concentration were 
added, dissolved with distilled water and made up to volume with distilled water. The 
solutions were sonicated for 15 minutes. After sonication the solutions were filtered 
through Whatmann filter paper No 41. Then by converting the zero order spectra to 
second order derivative spectra, the absorbance measurements were made for formulation 
at minima 234.5 nm and maxima 241.0 nm using water as blank. The amount of 
Dapoxetine present in formulation was calculated from the slope and intercept values. 
The procedure was repeated for three times at each level. 
 4.2.3.8 Limit of Detection (LOD) and Limit of Quantification (LOQ) 
 The calibration graph was prepared from the serial dilution of the standard 
solutions were repeated for six times. The Limit of Detection and Limit of Quantification 
were calculated by using the average of slope and of intercept values. 
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4.2.3.9 Ruggedness  
 Ruggedness of the method was performed by precision analysis, 
1. By using different analysts. 
2. By using different instruments. 
The Amount, SD, %RSD and Standard Error was calculated. 
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4.2.4 VISIBLE SPECTROPHOTOMETRIC METHOD 
4.2.4.1 Principle 
 Dapoxetine has tertiary amino group, hence it was planned to treat with           
0.01M Cerric Ammonium Sulphate and the resulting solution was tested for various color 
reactions with different chromogenic regents like MBTH, Fecl3, PDAB, FC. Where 
MBTH reagent gave a stable colour (wavelength of 400- 800nm) with Dapoxetine in 
presence oxidizing agent (0.01M Cerric Ammonium Sulphate) and have good linearity 
and obeys Beer’s Lambert law. 
     A=abc 
 [ A= absorbance, a= absorptivity, b= pathlength and c= concentration]  
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4.2.4.2 Method development 
4.2.4.2.1 Preparation of reagents 
1. MBTH 
 Weighed accurately about 0.2 gm of MBTH and dissolved in 100ml of distilled 
water. 
2. 0.01 M Cerric Ammonium Sulphate 
 Weighed accurately 0.632 gm of CAS in 100 ml of 1M Sulphuric acid. 
3. 1 M Sulphric acid  
 57 ml of concentrated Sulphuric acid in 1000ml. 
4.2.4.3 Optimization of MBTH reagent 
 Dapoxetine was found to yield a purple colored product with MBTH reagent and 
0.01 M Cerric Ammonium Sulphate and has absorbance maximum of 437 nm. Therefore 
studies were carried out to establish the mostly favorable condition for the formulation 
of the colored products. 
 The influence of the concentration with constant volumes of the reagent on the 
reaction has been studied. Various concentration of MBTH reagent like 1mL, 2mL, 
3mL, 4mL, and 5mL were tried by varying the parameter of 0.01M CAS concentration 
like 1mL, 2mL, 3mL, 4mL, and 5mL at a time, it was found to be 2mL and that of 
MBTH reagent was found to be 2mL. 
 The optimum concentration was selected on the basis of their ability to give 
maximum absorbance. The color was found to stable upto 2 hours. 
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4.2.4.4 Preparation of standard stock solution 
 10mg of Dapoxetine  working standard was accurately weighed and transferred 
into a 10 mL of volumetric flask and dissolved in minimum quality of distilled water 
and made upto 10mL distilled water. The solution was observed to contain 1000 µg/mL 
of Dapoxetine. 
4.2.4.5 Selection of λmax  
 To 1 mL standard stock solution, added 2 mL of 0.01M Cerric Ammonium 
Sulphate and 2 mL of  MBTH reagent in a 10 mL standard flask and the volume was 
made up to mark with distilled water. The solution was scanned between 400 to 800nm 
using reagent as blank. From the visible spectrum obtained, 437 nm was selected as λmax 
for the analysis of Dapoxetine. The color was found to be stable for 2 hours. 
4.2.4.6 Preparation of working standard solution 
An accurately weighed quantity of Dapoxetine (10mg) was dissolved in 
appropriate quantity of distilled water and transferred in a 100 mL volumetric flask, and 
then volume was made up with distilled water up to the mark to get 100µg/mL. A 
standard stock solution was further diluted with distilled water to get final solution of 
concentration 10 µg/mL. 
4.2.4.7 Linearity and calibration graph 
 In this method, the aliquots of working standards ( 0.5- 3 mL of  100 µg/mL ) 
were transferred into six 10 mL standard flasks, added 2mL of 0.01M Cerric Ammonium 
Sulphate and 2 mL of MBTH reagent, mixed well and allowed to stand for 5 min.        
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The solutions were made up to mark with the distilled water. The absorbance 
measurements were made at 437 nm against reagent as blank. The solutions were found 
to be linear from 5-30 µg/mL and the calibration curve was plotted between and 
absorbance. 
4.2.4.8 Quantification of formulation  
 Twenty tablets were weighed accurately and triturated to fine powder. The 
powder equivalent to 25mg Dapoxetine was weighed and transferred to 25ml volumetric 
flask. Dissolved with distilled water and sonicated for 15 minutes. The solution was made 
upto 25ml with distilled water filtered through Whatmann filter paper No.41and from the 
above solution pipette out 7.5ml and made up to 50ml with distilled water from that        
1 mL was pipetted out from the above solution and transferred into a 10 mL standard 
flask then added 2 mL Cerric Ammonium Sulphate and 2mL MBTH reagent. Volume 
was made up to mark with distilled water to get 15 µg/mL solution. The absorbance was 
measured at 437 nm using reagent as blank. The amount of Dapoxetine present in the 
formulation was calculated from the slope and intercept value of the calibration curve. 
4.2.4.9 Recovery studies 
 To determine the accuracy of the method, recovery study was performed by 
standard addition method. The recovery experiment was done by adding known 
concentration of Dapoxetine working standard to the pre analyzed formulation. To the 
50% of pre analyzed tablet powder equivalent to 25mg (labeled claim of tablet), known 
quantities of standard drug (80,100 and120 % of quantification concentration) were 
added, dissolved with distilled water and made up to volume with distilled water and 
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added 2mL of 0.01 M Cerric Ammonium Sulphate and 2 mL of MBTH reagent, mixed 
well and allowed to stand for 5 min. The solutions were made up to mark with the 
distilled water and filtered through whatmann filter paper No.41. The absorbance were 
made at 437 nm against reagent as blank. The amount of drug recovered from the 
formulation was calculated by using slope and intercept values. The procedure was 
repeated for three times at each level. 
4.2.4.10 Limit of Detection (LOD) and Limit of Quantification (LOQ) 
 The calibration graph was prepared from the serial dilution of the standard 
solutions were repeated for six times. The Limit of Detection and Limit of Quantification 
were calculated by using the average of slope and of intercept values. 
4.2.4.11 Ruggedness  
 Ruggedness of the method was performed by precision analysis, 
1. By using different analysts. 
2. By using different instruments. 
The Amount, SD, %RSD and Standard Error was calculated. 
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4.2.5 HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY METHOD 
4.2.5.1 Choice of mobile phase 
 Intial trials were made with prepared TLC plates and pre-coated sheets, the spots 
were identified using shorter wavelength in UV chamber and they are confirmed by 
scanning in HPTLC scanner and the individual standards are also spotted to determine 
the Rf of each drugs. 
TRAIL NO MOBILE PHASE RATIO 
1. Chloroform : Ammonia : Methanol 6 : 1 : 3 
2. Chloroform : Methanol : Acetic acid  6 : 3 : 1 
3. Acetonitile : Ethyl acetate 9 : 1 
4. Butanol : Acetic acid : Water 5 : 3 : 2 
5. Chloroform : Methanol : Water 6 : 3 : 1 
 
 The mobile phase chosen after trail was Acetonitrile : Ethyl acetate due to its 
better resolution. 
4.2.5.2 Detection of wavelength 
 10 µg/ml of Dapoxetine were prepared and the spectra were recorded in the range 
of 200 – 400 nm, from the spectra 292 nm was selected as detection wavelength. Where 
the drug showed maximum absorbance.  
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4.2.5.3 Optimized chromatographic conditions 
 Sample prepared in  - Methanol 
 Stationary phase  - silica gel 60 F 254 
 Mobile phase   - Acetonitrile : Ethyl acetate (9 : 1) 
 Scanning wavelength  - UV 292 nm 
 Development mode  - ascending mode 
 
4.2.5.4 Preparation of standard stock solution 
 A standard stock solution of Dapoxetine was prepared by dissolving in methanol 
to produce 100 µg/mL and solution was used to establish linearity. 
4.2.5.5 Evaluation of linearity 
 From stock solution of 100 µg/mL, from this 1-6 mL were pipetted out into a 
series of six 10mL volumetric flask, a final concentration of Dapoxetine ranging from 1 
to 6 µg/mL was obtained and this solution was spotted on a pre-coated TLC plates and 
developed as per the procedure discussed the peak area obtained for the different 
concentration. 
4.2.5.6 Calibration graph 
 A graph of peak area against concentration was constructed for Dapoxetine in the 
concentration range of 1 to 6 µg/mL and it was found to be linear. 
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4.2.5.7 Analysis of sample 
 Twenty tablets of formulation (Prilyxet 30) containing 30 mg of Dapoxetine were 
accurately weighed and the average weight was found and powdered. The powdered 
tablet equivalent to 10 mg of Dapoxetine was transferred into a 100 mL volumetric flask, 
added 25 mL of methanol and sonicated for 15min, then shaken vigorously for few min 
and finally made up to the mark with methanol. The above solution was collected by 
filtering it through Whatmann filter paper No.41. from the filtered solution, 3 µg/mL was 
spotted on a TLC aluminium sheets silica gel 60 F 254 plates are allowed to develop in 
twin trough chamber 20x10 cm using Acetonitrile : Ethyl acetate, the solvent front 
position is noted, the plates are then removed and allowed it to dry in hair drier for 5 min. 
The spots are then detected using Camag TLC scanner 3 and the peak area 
obtained at the detecting wavelength 292 nm, the amount of Dapoxetine was calculated 
using the regression equation. 
4.2.5.8 Recovery studies 
 The recovery studies were carried out by adding a known quantity of the standard 
drug to the pre-analysed formulation and the whole contents was re-analysed by the 
proposed method. The percentage recovery was calculated and the data was tabulated.     
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RESULTS AND DISCUSSION 
Six methods were performed and developed for the estimation of Dapoxetine in 
bulk pure form. The methods are employed for analysis of Dapoxetine were, 
 5.1 UV spectrophotometric method 
5.2 Area under curve method 
5.3 Derivative spectrophotometric method 
5.4 Visible spectrophotometric method 
5.5 HPTLC method. 
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5.1 UV SPECTROPHOTOMETRIC METHOD 
 The solubility status of Dapoxetine was performed as per Indian Pharmacopeia. 
The various polar and non-polar solvents were carried out for Dapoxetine were Distilled 
water, Methanol, Ethanol, 0.1 M Hydrochloric acid, Acetone, Ethyl acetate, Isopropyl 
alcohol, Acetonitrile, Dimethyl formamide, Diethyl ether, Chloroform, Carbon tetra 
chloride. 
 From the solubility studies, the Dapoxetine was found to be freely soluble in 
methanol and acetonitrile, ethyl acetate. Dapoxetine soluble in distilled water, acetone, 
and dimethyl formamide. It is insoluble in chloroform, carbon tetra chloride,                 
0.1 M Hydrochloric acid. 
 Dapoxetine is determined by dissolving in minimum quantity of distilled water 
and made further dilution with distilled water. The solution was scanned between 
wavelength range of 200 and 400 nm in the UV region using distilled water as a blank. 
From the UV spectrum obtained, 292 nm was chosen as maximum wavelength for further 
analysis of Dapoxetine. The UV spectrum are shown in figure 2.  
 By using the selected wavelength, the absorbance of solution of was observed and 
measured in different frequent intervals. It was found that the Dapoxetine having the 
stability for 4 hours and 30 minutes. So the same wavelength was selected for further 
analysis.  
 The different aliquots of Dapoxetine in distilled water were prepared in the 
concentration range from 5-30 µg/mL. The absorbance of the same solution was 
measured at 292 nm. The linearity procedure was repeated for six times. From the 
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linearity analysis, the calibration curve was plotted by using concentration against 
absorbance. The optical characteristics of Dapoxetine are correlation coefficient, 
regression equation, slope, intercept, limit of detection, limit of quantification, sandell’s 
sensitivity and standard error of mean were calculated. The reports are shown in the    
table 2. The average value of correlation coefficient from linearity studies was found to 
be 0.9999. It mentioned that the concentration of Dapoxetine has good linearity. The 
calibration graph were shown in figure 6. 
 The amount of Dapoxetine was determined in the test solution by using average 
values of slope and intercept. Repeated the same procedure for six times. The average 
percentage label claim of Dapoxetine present in tablet formulation (Prilyxet 30) was 
found to be 100.6 ± 0.428657. The percentage relative standard deviation value revealed 
that the proposed method has good precision. The results of this analysis are shown in 
table 3. 
  The precision of the proposed method was further ensured by carry out the 
recovery analysis. To the 50% of pre-analyzed tablet formulation, a known quantities of 
Dapoxetine standard solution was added at different levels (80%, 100% and 120% of 
quantification concentration). The absorbance of the recovery solutions were measured at 
292 nm and the percentage purity of recovery analysis were found to be 100.03%. 
 It was revealed that the excipients did not interface in the tablet formulation of 
Dapoxetine. The recovery analysis are shown in table 4. 
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 Further, the precision of the proposed method was confirmed by intraday and 
interday analysis of quantification studies, the quantification analysis was performed for 
three times in the same day and one time in the three successive days. 
 The %RSD values were found to be 0.210207 and 0.013981 for intraday and 
interday analysis of formulation, the low percentage RSD revealed that the precision of 
the proposed method was ensured. The results of interday and intraday analysis are 
shown in table 5. 
 The method was developed and validated by ruggedness analysis. It was 
performed by different days which may consists different analysts and different 
instruments. The % RSD values were found to be 1.559669 and 0.743303 for different 
instruments and different analysts respectively. The reports of ruggedness analysis were 
shown in table 6. Hence the precision was ensured by ruggedness analysis. 
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5.2 AREA UNDER THE CURVE METHOD 
 The solubility status of Dapoxetine was performed as per Indian Pharmacopeia. 
The various polar and non-polar solvents were carried out for Dapoxetine  were Distilled 
water, methanol, ethanol, 0.1M Hydrochloric acid, acetone, ethyl acetate, isopropyl 
alcohol, acetonitrile, dimethyl formamide, diethyl ether, chloroform, carbon tetra 
chloride. 
 From the solubility studies, the Dapoxetine was found to be freely soluble in 
methanol and acetonitrile, ethyl acetate. Dapoxetine soluble in distilled water, acetone, 
and dimethyl formamide. It is insoluble in chloroform, carbon tetra chloride,                  
0.1M Hydrochloric acid. 
 Dapoxetine is determined by dissolving in minimum quantity of distilled water 
and made further solution with distilled water. The solution was scanned between 
wavelength range of 200 and 400 nm in the UV region using distilled water as a blank. 
From the UV spectrum obtained, 281.5 nm and 295.5 nm was chosen as wavelength for 
further analysis of Dapoxetine. The Area under curve spectrum are shown in figure 3.   
 By using the selected wavelength, the absorbance of solution was observed and 
measured in different frequent intervals. It was found that the Dapoxetine having the 
stability for 4 hours and 30 minutes. So the same wavelength was selected for further 
analysis.  
 The different aliquots of Dapoxetine in distilled water prepared in the 
concentration range from 5-30 µg/mL. The absorbances of the same solution were 
measured at 281.5 nm and 295.5 nm. The linearity procedure was repeated for six times. 
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From the linearity analysis, the calibration curve was plotted by using concentration 
against absorbance. The optical characteristics of Dapoxetine are correlation coefficient, 
regression equation, slope, intercept, limit of detection, limit of quantification, sandell’s 
sensitivity and standard error of mean were calculated. The reports are shown in the    
table 7. The average value of correlation coefficient from linearity studies was found to 
be 0.9996. It mentioned that the concentration of Dapoxetine  has good linearity. The 
calibration graph are shown in figure 7. 
 The amount of Dapoxetine was determined in the test solution by using average 
values of slope and intercept. Repeated the same procedure for six times. The average 
percentage label claim of Dapoxetine present in tablet formulation (Prilyxet 30) was 
found to be 99.3 ± 0.08165. The percentage relative standard deviation value revealed 
that the proposed method has good precision. The results of this analysis are shown in 
table 8. 
  The precision of the proposed method was further ensured by carry out the 
recovery analysis. To the 50% of pre-analyzed tablet formulation, a known quantities of 
Dapoxetine standard solution was added at different levels (80%, 100% and 120% of 
quantification concentration). The absorbance of the recovery solutions were measured at 
281.54 and 295.5 nm and the percentage purity of recovery analysis was found to be 
100.74%. 
 It was revealed that the excipients did not interface in the tablet formulation of 
Dapoxetine. The recovery analysis are shown in table 9. 
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 Further, the precision of the proposed method was confirmed by intraday and 
interday analysis of quantification studies, the quantification analysis was performed for 
three times in the same day and one time in the three successive days. 
 The %RSD values were found to be 0.057948 and 0.057948 for intraday and 
interday analysis of formulation, the low percentage RSD revealed that the precision of 
the proposed method was ensured. The results of interday and intraday analysis are 
shown in table 10. 
 The method was developed and validated by ruggedness analysis. It was 
performed by different days which may consists different analysts and different 
instruments. The % RSD values were found to be and 0.743303 for different instruments 
and different analysts respectively. The reports of ruggedness analysis were showed in 
table 11. Hence the precision was ensured by ruggedness analysis. 
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5.3 DERIVATIVE SPECTROPHOTOMETRIC METHOD 
The various polar and non-polar solvents were carried out for Dapoxetine  were 
Distilled water, methanol, ethanol, 0.1M Hydrochloric acid, acetone, ethyl acetate, 
isopropyl alcohol, acetonitrile, dimethyl formamide, diethyl ether, chloroform, carbon 
tetra chloride. 
 From the solubility studies, the Dapoxetine was found to be freely soluble in 
methanol and acetonitrile, ethyl acetate. Dapoxetine soluble in distilled water, acetone, 
and dimethyl formamide. It is insoluble in chloroform, carbon tetra chloride,             
0.1M Hydrochloric acid. 
 Dapoxetine is determined by dissolving in minimum quantity of distilled water 
and made further solution with distilled water. The solution was scanned between 
wavelength range of 200 and 400 nm in the UV region using distilled water as a blank. 
The zero order spectrum obtained was derivatised to second order derivative spectrum. 
From the derivative spectra obtained, 241 nm and 234.5 nm were chosen as maxima and 
minima wavelength for further analysis of Dapoxetine. The derivative spectrum is shown 
in figure 4. 
By using the selected wavelength, the absorbance of solution was observed and 
measured in different frequent intervals. It was found that the Dapoxetine having the 
stability for 4 hours and 30 minutes. So the same wavelength was selected for further 
analysis.  
The different aliquots of Dapoxetine in distilled water were prepared in the 
concentration range from 5-30 µg/mL. The absorbance of the same solution were 
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measured at minima 234.5 nm and maxima 241 nm. The linearity procedure was repeated 
for six times. From the linearity analysis, the calibration curve was plotted by using 
concentration against absorbance. The optical characteristics of Dapoxetine are 
correlation coefficient, regression equation, slope, intercept, limit of detection, Limit of 
quantification, sandell’s sensitivity and standard error of mean were calculated. The 
reports are shown in the table 12. The average value of correlation coefficient from 
linearity studies was found to be 0.9999. It mentioned that the concentration of 
Dapoxetine has good linearity. The calibration graph are shown in figure 8. 
 The amount of Dapoxetine was determined in the test solution by using average 
values of slope and intercept. Repeated the same procedure for six times. The average 
percentage label claim of Dapoxetine present in tablet formulation (prilyxet 30) was 
found to be 99.84 ± 0.869768. The percentage relative standard deviation value revealed 
that the proposed method has good precision. The results of those analysis are shown in 
table 13. 
  The precision of the proposed method was further ensured by carry out the 
recovery analysis. To the 50% of pre-analyzed tablet formulation, a known quantities of 
Dapoxetine standard solution was added at different levels (80%, 100% and 120% of 
quantification concentration). The absorbance of the recovery solutions were measured at 
234.5 nm and 241 nm. The percentage purity of recovery analysis was found to be 
100.12%. 
 It was revealed that the excipients did not interface in the tablet formulation of 
Dapoxetine. The recovery analysis are shown in table 14. 
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 Further, the precision of the proposed method was confirmed by intraday and 
interday analysis of quantification studies, the quantification analysis was performed for 
three times in the same day and one time in the three successive days. 
 The %RSD values were found to be 0.692128 and 0.050103 for intraday and 
interday analysis of formulation, the low percentage RSD revealed that the precision of 
the proposed method was ensured. The results of interday and intraday analysis are 
shown in table 15. 
 The method was developed and validated by ruggedness analysis. It was 
performed by different days which may consists different analysts and different 
instruments. The % RSD values were found to be 0.071173 and 0.692128 for different 
instruments and different analysts respectively. The reports of ruggedness analysis were 
showed in table 16. Hence the precision was ensured by ruggedness analysis. 
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5.4 VISIBLE SPECTROPHOTOMETRIC METHOD 
 Dapoxetine has tertiary amino group, hence it was planned to treat with        
0.01M Cerric Ammonium Sulphate and the resulting solution was tested for various color 
reactions with different chromogenic regents like MBTH, Fecl3, PDAB, FC. Where 
MBTH reagent gave a stable purple colour with Dapoxetine in presence of oxidizing 
agent (0.01M Cerric Ammonium Sulphate). From solubility studies, the distilled water 
was selected as a choice of solvent for the proposed method. 
 The stability of the colored solution was found up to 2 hours and there is no 
change in absorbance. The 10 µg/mL solution was prepared and scanned from             
400 to 800 nm. The visible spectrum was obtained, from the visible spectra shows a 
maximum absorbance at 437 nm. The visible spectrum shown in the figure 5. 
Dapoxetine was found to yield a purple colored product with MBTH reagent and 
0.01M Cerric Ammonium Sulphate and has absorbance maximum of 437 nm. Therefore 
studies were carried out to establish the mostly favorable condition for the formation of 
these colored products. 
The influence of the concentration with constant volumes of the reagent on the 
reaction has been studied. Various concentration of MBTH reagent like 1mL, 2mL, 3mL, 
4mL, and 5mL were tried by varying the parameter of 0.01M CAS concentration like 
1mL, 2mL, 3mL, 4mL, and 5mL at a time, it was found that the optimum concentration 
of 0.01M Cerric Ammonium Sulphate was found to be 2 mL and that of MBTH reagent 
was found to be 2 mL. 
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Dapoxetine was dissolved in distilled water, and made up to the volume with 
distilled water to get a concentration of 1000 µg/mL. Then prepared 100 µg/mL solution 
using distilled water, from which a linearity of 5-30 µg/mL was made and measured the 
absorbance at 437nm. The calibration curve was made by using concentration against 
absorbance were shown in the figure 9. 
The optical characteristics of Dapoxetine are correlation coefficient, regression 
equation, slope, intercept, Limit of detection, Limit of quantification, sandell’s sensitivity 
and standard error of mean were calculated. 
Correlation coefficient was found to be close to 1, intimate that it has good 
linearity and obey’s Beer’s Lambert’s law. The limit of detection, limit of quantification 
were found from the linearity analysis by using average of slope and intercept values. 
The results are shown in Table 17. 
Assay of commercial formulation involved using 15 µg/mL solution. The amount 
of drug present in the marked formulation was determined by average values of slope and 
intercept and the average percentage label claim was found to be 99.0 ± 0.250333. The 
results of this analysis are shown in table 18. 
To determine the accuracy of the method by using recovery analysis, known 
amount of pure drug (80, 100 and 120% of quantification concentration) were added to 
the previously analyzed solutions. The absorbance of the recovery solutions were 
measured at 437 nm. The percentage recovery was found to 100.0%. The results of 
recovery analysis are shown in table 19. 
 93 
 
The precision studies were carried out by intraday and interday repeatability 
studies for assay. The results of quantification for intraday and interday 0.300595 and 
2.072575 respectively. The results are shown in table 20. 
The method was developed and validated by ruggedness analysis. It was 
performed by different days which may consist different analysts and different 
instruments. The % RSD values were found to be 0.142132 and 0.070959 for different 
instruments and different analysts respectively. The reports of ruggedness analysis were 
showed in table 21. Hence the precision was ensured by ruggedness analysis 
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5.5 HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY METHOD 
         Various mobile phase systems were prepared and trails were made with pre-coated 
plates to determine appropriate chromatographic conditions. The mobile phase finalized 
for HPTLC analysis was Acetonitrile : Ethyl acetate in the ratio of 9 : 1 v/v and the 
chromatogram was developed. The scanning of the developed plates shows a good peak 
shape. 
The linearity of HPTLC method developed for Dapoxetine was evaluated by 
injecting the standard drug solutions of different concentration ranging from                     
1 to 6 µg/mL and the peak areas obtained are presented in figure 12-17. The calibration 
curve was made by using concentration against absorbance were shown in the figure 18. 
The various optical parameters like Regression equation, Slope, Intercept, 
Sandell’s sensitivity, standard error of mean were calculated and the best results are 
presented in Table 22 
The Assay determined the contents of Dapoxetine in formulation (Priliyxet 30) 
were found to be 100.45%. The assay results presented in the table 23. The 
chromatograms are shown in figure 19. 
The Accuracy and precision was determined for Dapoxetine by fortifying sample 
with standard drug substance at a concentration range 2.4, 3.0, 3.6 µg/mL and overall 
recovery determined, The data presented in the table 24. The Chromatograms are shown 
in figures 20 and respectively. The results of quantification for intraday and interday 
0.55075 and 0.30550 respectively. The results are shown in table 25. 
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Hence it is concluded that the developed UV visible and HPTLC methods are 
found to be simple, precise and accurate for the analysis of Dapoxetine in pure form and 
in pharmaceutical formulation. 
Among the established analytical methods, HPTLC method can be applied for 
regular analysis of Dapoxetine from pure and pharmaceutical dosage form. 
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SUMMARY AND CONCLUSION 
 Standard analytical studies for newer formulation drugs may not be available in 
pharmacopeias, since it is necessary to develop analytical estimation of which are simple, 
accurate, precise, economic, specific, rapid and linear. 
Methods employed were 
 6.1 UV spectrophotometric method 
6.2 Area under curve method 
6.3 Derivative spectrophotometric method 
6.4 Visible spectrophotometric method 
6.5 HPTLC method. 
6.1 UV SPECTROPHOTOMETRIC METHOD 
 The estimation of Dapoxetine was achieved by UV spectrophotometric method. 
By considering the solubility status and stability studies, the distilled water was selected 
as suitable solvent and further analysis were made by using the distilled water. 10 µg/mL 
solution of Dapoxetine was prepared from the stock solution and scanned in the UV 
region and λmax was found at 292nm. Dapoxetine obey’s Beer’s law and it was ensured 
from the calibration graph in the range of 5-30 µg/mL. From marketed formulation,       
15 µg/mL concentration was prepared by using the same solvent. The percentage label 
claim of Dapoxetine in tablet formulation was found to be 100.6 ± 0.428657. The 
precision of the proposed method was carried out by performing the repeated analysis. 
The recovery studies were also performed to determine the accuracy of the UV method 
by adding the 50% of pre-analysed formulation. The average percentage recovery 
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analysis for formulation (Prilyxet 30) was found to be 100.3%. The precision of the same 
method was determined by intraday and interday analysis on assay.  Also the % RSD 
values were found to be 0.210207 and 0.013981 for intraday and interday analysis of 
formulation. Also the precision analysis was further performed by ruggedness analysis 
using different analysts and different instruments. 
6.2 AREA UNDER THE CURVE METHOD 
 The evaluation of Dapoxetine was reached by Area under curve method. From the 
analysis of solubility status and stability studies, the water was selected as suitable 
solvents for further analysis. 10 µg/mL solution of Dapoxetine was prepared from the 
stock solution and scanned in the UV region. From the area under curve spectrum, the 
area between 281.5 nm and 295.5 nm was selected as wavelength for further analysis. 
Dapoxetine was obey’s beer’s law and it was ensured from the calibration graph in the 
range of 5-30 µg/mL. From the commercial formulation, 15 µg/mL concentration of 
Dapoxetine was prepared by using the same solvent. The percentage label claim of 
Dapoxetine in tablet formulation was found to be 99.3 ± 0.08165. The precision of the 
proposed method was performed by carry out the repeated analysis. The recovery 
analysis was also performed to determine the accuracy of the area under curve method by 
adding the 50% of pre-analysed formulation. The average percentage recovery analysis 
for marketed formulation (Prilyxet 30) was found to be 100.74%. The precision of the 
some method was achieved by intraday and interday analysis on assay. Also the precision 
analysis was further confirmed by ruggedness analysis using different analysts and 
different instruments  
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6.3 DERIVATIVE SPECTROPHOTOMETRIC METHOD 
 The estimation of Dapoxetine was accomplished by derivative spectrophotometric 
method. In the view of solubility status and stability studies, the distilled water was 
picked out as best solvent for further analysis. 10 µg/mL of Dapoxetine solution was 
prepared from the stock solution and scanned in the UV region. From the derivative 
spectrum, 234.5 and 241 nm was selected as the minimum and maximum wavelength for 
further analysis. Dapoxetine obey’s Beer’s law and it was ensured from the calibration 
graph in the range 5-30 µg/mL. From the formulation, 15 µg/mL concentration was 
prepared by using the same solvent. The percentage label claim of Dapoxetine in the 
commercial tablet formulation was found to be 99.84 ± 0.869768. The precision of the 
proposed method was carried out by performing the repeated analysis. The recovery 
studies were also performed to determine the accuracy of the derivative 
spectrophotometric method by adding the 50% of pre-analysed formulation. The average 
percentage recovery analysis for formulation (Prilyxet 30) was found to be 100.12%. The 
precision of the same method was determined by intraday and interday analysis of 
formulation. Also the precision analysis was further performed by ruggedness analysis 
using different analysts and different instruments. The %RSD values were found to be 
0.071173 for different instrument and 0.692128 for different analysts. 
6.4 VISIBLE SPECTROPHOTOMETRIC METHOD 
 The assessment of Dapoxetine was studied by visible spectrophotometric method. 
The reagent used was MBTH reagent and 0.01M Cerrric Ammonium Sulphate 10 µg/mL 
solution of Dapoxetine was prepared from the stock solution and reagents were added to 
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get stable purple colour. The solution was scanned in the visible region               
(wavelength 400-800 nm). From the visible spectrum, 437 nm was selected as the 
maximum wavelength further analysis. Calibration graph was plotted by using the 
concentration versus absorbance. Dapoxetine obey’s Beer’s law and it was ensured from 
the calibration graph in the range of 5-30 µg/mL. From the tablet formulation, 15 µg/mL 
concentration was prepared by using the same solvent and reagents were added. The 
amount of Dapoxetine in tablet formulation was found to be 99.0 ± 0.25033. The 
precision of the planned method was carried out by performing the repeated analysis. The 
recovery analysis studies were also performed to determine the accuracy of the visible 
spectrophotometric method by adding the previously analyzed tablet formulation. The 
average percentage recovery analysis for formulation (Prilyxet 30) was found to be 
100.00%. The precision of the same method was determined by intraday and interday 
analysis on assay. Also the precision analysis was further performed by ruggedness 
analysis using different analysts and different instruments. 
6.5 HPTLC METHOD 
 Estimation Dapoxetine was achieved by HPTLC method, after performing various 
trails of mobile phase, Acetonitrile : Ethyl acetate (9 : 1 v/v) was selected as mobile 
phase. After eluting, the spots were scanned in the TLC chamber. From that, 292 nm was 
selected as analyzing wavelength. Calibration curve was plotted by concentration against 
peak area. 
 The percentage label claim of Dapoxetine in formulation ( Prilyxet 30 ) was found 
to be 100.45 ± 0.29263. The precision of the method was studied by making repeated 
100 
 
analysis. The recovery studies also carried to ensure the accuracy of the method by 
adding concentration of drug to a pre-anlyzed formulation and the %RSD was found to 
be 0.2913. 
 The proposed methods could be successfully applied to estimate commercial 
pharmaceutical product containing Dapoxetine. Thus the above studies and finding will 
enable the above quantification of the drug for the investigation in the field of analytical 
chemistry. 
 Among the established analytical methods, HPTLC method was found to be more 
precise, time consuming and accurate.    
 
 
 
 
 
FIGURES 
 
 
 
FIGURE.1 
IR SPECTRUM OF DAPOXETINE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE.2 
UV SPECTRUM OF DAPOXETINE IN  
DISTILLED WATER 
 
 
  
FIGURE.3 
AREA UNDER CURVE SPECTRUM OF DAPOXETINE IN  
DISTILLED WATER 
 
 
 
 
  
FIGURE.4 
DERIVATIVE SPECTRUM OF DAPOXETINE IN DISTILLED WATER 
 
 
 
  
FIGURE.5 
VISIBLE SPECTRUM OF DAPOXETINE IN DISTILLED WATER 
 
  
 FIGURE.6 
CALIBRATION CURVE OF DAPOXETINE BY UV 
SPECTROPHOTOMETRIC METHOD USING DISTILLED WATER AT 292 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE.7 
CALIBRATION CURVE OF DAPOXETINE BY AREA UNDER CURVE 
METHOD USING DISTILLED WATER AT 281.5 nm AND 295.5 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE.8 
CALIBRATION CURVE OF DAPOXETINE BY DERIVATIVE 
SPECTROPHOTOMETRIC METHOD USING DISTILLED WATER AT          
234.5 nm AND 241.0 nm. 
 
 
 
 
 
 
 
 
 
 
            
            
            
    
 
FIGURE.9 
CALIBRATION CURVE OF DAPOXETINE BY VISIBLE 
SPECTROPHOTOMETRIC METHOD USING MBTH REAGENT AT 437nm. 
 
           
            
            
            
            
            
            
            
            
            
            
            
            
   
 
 
 
FIGURE.10 
UV SPECTRA OF DAPOXETINE IN MOBILE PHASE             
ACETONITRILE : ETHYL ACETATE (9 : 1 V/V) 
 
  
FIGURE.11  
SPECTRAL CONFORMATION OF STANDARD DAPOXETINE WITH 
FORMULATION 
  
FIGURE.12  
LINEARITY CHROMATOGRAM OF DAPOXETINE BY HPTC METHOD 
(1µg/mL) 
 
 
 
  
FIGURE.13  
LINEARITY CHROMATOGRAM OF DAPOXETINE BY HPTLC METHOD 
(2µg/mL) 
 
 
 
 
  
FIGURE.14 
          LINEARITY CHROMATOGRAM OF DAPOXETINE BY HPTLC METHOD          
(3 µg/mL) 
 
  
FIGURE.15  
          LINEARITY CHROMATOGRAM OF DAPOXETINE BY HPTLC METHOD        
(4 µg/mL) 
 
 
  
FIGURE.16  
          LINEARITY CHROMATOGRAM OF DAPOXETINE BY HPTLC METHOD        
(5 µg/mL) 
 
 
  
FIGURE.17 
LINEARITY CHROMATOGRAM OF DAPOXETINE BY HPTLC METHOD         
(6 µg/mL) 
 
 
  
FIGURE.18 
CALIBRATION CURVE OF DAPOXETINE BY HPTLC METHOD AT 292 nm 
 
 
 
 
  
FIGURE.19 
CHROMATOGRAM ANALYSIS OF FORMULATION – (PRILYXET 30) 
  
FIGURE.20 
CHROMATOGRAM OF RECOVERY OF FORMULATION        
(PRILYXET 30) – 2.4 µg/mL, 3.0 µg/mL, 3.6 µg/mL 
 
 
 
 
 
 
TABLES 
 
 
 
TABLE.1 
SOLUBILITY STUDIES FOR DAPOXETINE HYDROCHLORIDE IN 
POLAR AND NON-POLAR SOLVENTS 
 
 
 
 
 
 
 
 
S.No Solvent Solubility Solubility status 
1. Water 1 in 200 µL Soluble 
2. 0.1 M Hydrochloric acid More than 10,000 parts Insoluble 
3. Ethanol 1 in 50 µL Freely soluble 
4. Methanol 1 in 50 µL Freely soluble 
5. Acetone 1 in 100 µL Soluble 
6. Ethyl acetate 1 in 50 µL Freely soluble 
7. Isopropyl alcohol 1 in 50 µL Freely soluble 
8. Acetonitrile 1 in 50 µL Freely soluble 
9. Dimethyl formamide 1 in 100 µL Soluble 
10. Diethyl ether More than 10,000 parts Insoluble 
11. Chloroform More than 10,000 parts Insoluble 
12. Carbon tetra chloride More than 10,000 parts Insoluble 
TABLE.2 
OPTICAL CHARACTERISTICS OF DAPOXETINE HYDROCHLORIDE BY UV 
SPECTROPHOTOMETRIC METHOD 
 
S.No Parameters UV spectrophotometric method 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
7. 
 
8. 
 
9. 
 
 
10. 
 
 
λmax (nm) 
 
Beer’s law limit (µg/mL) 
 
Correlation coefficient (r) 
 
Regression equation (Y=mx+c) 
 
Slope (m) 
 
Intercept (c) 
 
LOD (µg/mL) 
 
LOQ (µg/mL) 
 
Sandell’s sensitivity 
(µg/cm2/0.001 A.U.) 
 
Standard error of mean 
 
 
292 nm 
 
5-30 
 
0.9999 
 
            Y= 0.016936 x + - 0.00280 
 
0.016936 
 
-0.00280 
 
0.736215896 
 
2.23095726 
 
0.059044 
 
 
0.002593. 
 
 
 
 
 
 
 
 
 
 
TABLE.3 
QUANTIFICATION OF FORMULATION (PRILYXET 30) BY UV 
SPECTROPHOTOMETRICMETHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
Labelled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab) 
Percentage 
obtained 
(%) 
Average 
percentage 
found 
S.D 
(+/-) %R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
 
30 
 
30 
 
30 
 
30 
 
30 
 
30 
 
 
29.99 
 
30.17 
 
29.97 
 
30.21 
 
29.96 
 
29.93 
 
 
99.66% 
 
100.5% 
 
99.9% 
 
100.7% 
 
99.86% 
 
99.76% 
 
 
100.6% 
 
0.428657 0.428386 
 
0.011907 
 
TABLE.4 
RECOVERY STUDIES OF FORMULATION (PRILYXET 30) BY UV 
SPECTROPHOTOMETRICMETHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.
No 
 
Amount 
present 
(µg/mL) 
Amount 
added 
(µg/mL) 
Amount 
estimated 
(µg/mL) 
Amount 
recovered
(µg/mL) 
Percentage 
recovered 
(%) 
Average 
percentage 
recovered 
± S.D  
% 
R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
15.02 
 
15.02 
 
15.02 
12 
 
15 
 
18 
26.93 
 
30.25 
 
32.90 
11.91 
 
15.23 
 
17.88 
99.27 
 
101.5 
 
99.33 
100.03% 
± 
1.292014 
1.2918 0.1435 
TABLE.5 
INTRADAY AND INTERDAY PRECISION ANALYSIS OF 
FORMULATION (PRILYXET 30) BY UV SPECTROPHOTOMETRIC METHOD 
 
 
S.No 
Labeled 
obtained 
(mg/tab) 
Percentage 
obtained 
(%) 
S.D 
(+/-) % R.S.D 
Intraday Interday Intraday Interday Intraday Interday
1. 30 99.10 99.0 
0.208407 0.125831 0.210207 0.0139812. 30 99.37 99.25 
3. 30 98.96 99.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE.6 
RUGGEDNESS ANALYSIS OF FORMULATION (PRILYXET 30) BY UV 
SPECTROPHOTOMETRICMETHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Condition 
Average 
percentage 
obtained 
(%) 
S.D 
(+/-) %R.S.D S.E 
1. Analyst 1 99.61% 
0.741148 0.743303 0.08285 2. Analyst 2 99.01% 
3. Instrument 1 99.21% 
1.537314 1.559669 0.170813 4. Instrument 2 99.07% 
TABLE.7 
OPTICAL CHARACTERISTICS OF DAPOXETINE HYDROCHLORIDE BY 
AREA UNDER CURVE METHOD 
 
S.No Parameters Area under curve method 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
7. 
 
8. 
 
9. 
 
 
10. 
 
 
Selected area (nm) 
 
Beer’s law limit (µg/mL) 
 
Correlation coefficient (r) 
 
Regression equation (Y=mx+c) 
 
Slope (m) 
 
Intercept (c) 
 
LOD (µg/mL) 
 
LOQ (µg/mL) 
 
Sandell’s sensitivity 
(µg/cm2/0.001 A.U.) 
 
Standard error of mean 
 
281.5 - 295.5 nm 
 
5-30 
 
0.9996 
 
          Y= 0.2338885 x + 0.075698306. 
 
0.2338885 
 
0.075698306 
 
2.609704467 
 
7.908195355 
 
0.004275542 
 
 
0.075698306 
 
 
 
 
 
 
 
 
 
 
TABLE.8 
QUANTIFICATION OF FORMULATION (PRILYXET 30) BY AREA UNDER 
CURVE METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
Labelled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)
Percentage 
obtained 
(%) 
Average 
percentage 
found 
S.D 
(+/-) %R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
 
30 
 
30 
 
30 
 
30 
 
30 
 
30 
 
 
29.79 
 
29.78 
 
29.79 
 
29.78 
 
29.79 
 
29.79 
 
 
99.3% 
 
99.3% 
 
99.3% 
 
99.3% 
 
99.3% 
 
99.3% 
 
 
99.3% 
 
0.08165 0.082198 0.002268
TABLE.9 
RECOVERY STUDIES OF FORMULATION (PRILYXET 30) BY AREA UNDER 
CURVE METHOD 
 
 
S.
No 
 
Amount 
present 
(µg/mL) 
Amount 
added 
(µg/mL) 
Amount 
estimated 
(µg/mL) 
Amount 
recovered
(µg/mL) 
Percentag
e 
recovered 
(%) 
Average 
percentage 
recovered 
± S.D  
% R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
    14.90 
 
14.90 
 
14.90 
12 
 
15 
 
18 
26.94 
 
29.99 
 
33.15 
12.04 
 
15.09 
 
18.25 
100.33 
 
100.6 
 
101.3 
100.74% 
± 
0.500633 
0.496939 0.055626 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE.10 
INTRADAY AND INTERDAY PRECISION ANALYSIS OF FORMULATION 
(PRILYXET 30) BY AREA UNDER CURVE METHOD 
 
 
S.No 
Labeled 
obtained 
(mg/tab) 
Percentage 
obtained 
(%) 
S.D 
(+/-) % R.S.D 
Intraday Interday Intraday Interday Intraday Interday
1. 30 99.6 99.6 
0.057735 0.057735 0.057948 0.0579482. 30 99.7 99.7 
3. 30 99.6 99.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE.11  
RUGGEDNESS ANALYSIS OF FORMULATION (PRILYXET 30) BY                      
AREA UNDER CURVE METHOD 
 
 
S.No Condition 
Average 
percentage 
obtained 
(%) 
S.D 
(+/-) 
%R.S.D S.E 
1. Analyst 1 99.6 
0.070711 0.070959 0.017678 
2. Analyst 2         99.7 
3. Instrument 1 99.6 
0.141421 0.142132 0.035355 
4. Instrument 2 99.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE.12 
OPTICAL CHARACTERISTICS OF DAPOXETINE HYDROCHLORIDE BY 
DERIVATIVE SPECTROPHOTOMETRIC METHOD 
 
 
S.No Parameters Derivative spectrophotometric method 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
7. 
 
8. 
 
9. 
 
 
10. 
 
 
λmax (nm) 
 
Beer’s law limit (µg/mL) 
 
Correlation coefficient (r) 
 
Regression equation (Y=mx+c) 
 
Slope (m) 
 
Intercept (c) 
 
LOD (µg/mL) 
 
LOQ (µg/mL) 
 
Sandell’s sensitivity 
(µg/cm2/0.001 A.U.) 
 
Standard error of mean 
 
 
234.5 and 241 nm 
 
5-30 
 
0.99984 
 
          Y= 0.002721857 x + 0.000745. 
 
0.002721857 
 
0.000745 
 
2.212485893 
 
6.704502708 
 
 
0.367396211 
 
                         0.000564186 
 
 
 
 
 
 
 
 
TABLE.13 
QUANTIFICATION OF FORMULATION (PRILYXET 30) BY DERIVATIVE 
SPECTROPHOTOMETRIC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
Labelled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab) 
Percentage 
obtained 
(%) 
Average 
percentag
e found 
S.D 
(+/-) %R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
 
30 
 
30 
 
30 
 
30 
 
30 
 
30 
 
 
30.07 
 
30.23 
 
29.93 
 
29.55 
 
29.77 
 
30.23 
 
 
100.2% 
 
100.7% 
 
99.76% 
 
98.5% 
 
99.23% 
 
100.7% 
 
 
99.84% 
 
0.869768 0.871089 0.02416
TABLE.14 
RECOVERY STUDIES OF FORMULATION (PRILYXET 30) BY DERIVATIVE 
SPECTROPHOTOMETRIC METHOD 
 
 
S.
No 
 
Amount 
present 
(µg/mL) 
Amount 
added 
(µg/mL) 
Amount 
estimated 
(µg/mL) 
Amount 
recovered
(µg/mL) 
Percentage 
recovered 
(%) 
Average 
percentag
e 
recovered 
± S.D  
% 
R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
15.04 
 
15.04 
 
15.04 
12 
 
15 
 
18 
27.06 
 
29.99 
 
33.15 
12.02 
 
14.95 
 
18.11 
100.1 
 
99.66 
 
100.6 
100.12% 
± 
0.4703 
0.4697 0.5522
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE.15 
INTRADAY AND INTERDAY PRECISION ANALYSIS OF FORMULATION 
(PRILYXET 30) BY DERIVATIVE SPECTROPHOTOMETRICMETHOD 
 
 
 
S.No 
Labeled 
obtained 
(mg/tab) 
Percentage 
obtained 
(%) 
S.D 
(+/-) % R.S.D 
Intraday Interday Intraday Interday Intraday Interday
1. 30 100.5 99.6 
0.69282 0.450925 0.692128 0.0501032. 30 100.5 100.1 
3. 30 99.3 100.5 
 
 
 
 
 
 
 
 
 
 
 
TABLE.16 
RUGGEDNESS ANALYSIS OF FORMULATION (PRILYXET 30) BY 
DERIVATIVE SPECTROPHOTOMETRICMETHOD 
 
 
S.No Condition 
Average 
percentage 
obtained (%) 
S.D 
(+/-) 
%R.S.D S.E 
1. Analyst 1 99.03% 
1.039447 0.692128 0.259862 
2. Analyst 2     100.5% 
3. Instrument 1 99.3% 
0.070711 0.071173 0.017678 
4. Instrument 2 99.3% 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE.17 
OPTICAL CHARACTERISTICS OF DAPOXETINE HYDROCHLORIDE BY 
VISIBLE SPECTROPHOTOMETRIC METHOD 
 
S.No Parameters Visible Spectrophotometric method 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
7. 
 
8. 
 
9. 
 
 
10. 
 
 
λmax (nm) 
 
Beer’s law limit (µg/mL) 
 
Correlation coefficient (r) 
 
Regression equation (Y=mx+c) 
 
Slope (m) 
 
Intercept (c) 
 
LOD (µg/mL) 
 
LOQ (µg/mL) 
 
Sandell’s sensitivity 
(µg/cm2/0.001 A.U.) 
 
Standard error of mean 
 
 
437 
 
5-30 
 
0.9996 
 
          Y= 0.025741 x + 0.008289 
 
0.025741 
 
0.008289 
 
1.117265968 
 
3.385654449 
 
 
0.039070785 
 
                         0.001399969 
 
 
 
 
 
 
 
 
 
 
TABLE.18 
QUANTIFICATION OF FORMULATION (PRILYXET 30) BY VISIBLE 
SPECTROPHOTOMETRICMETHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
Labelled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab) 
Percentage 
obtained 
(%) 
Average 
percentage 
found 
S.D 
(+/-) %R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
 
30 
 
30 
 
30 
 
30 
 
30 
 
30 
 
 
29.67 
 
29.77 
 
29.71 
 
29.61 
 
29.77 
 
29.83 
 
 
98.9% 
 
99.2% 
 
99.0% 
 
98.7% 
 
99.2% 
 
99.4% 
 
 
99.0% 
 
0.250333 0.252692 0.006954 
TABLE.19 
RECOVERY STUDIES OF FORMULATION (PRILYXET 30) BY VISIBLE 
SPECTROPHOTOMETRICMETHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.
No 
 
Amount 
present 
(µg/mL) 
Amount 
added 
(µg/mL) 
Amount 
estimated 
(µg/mL) 
Amount 
recovered
(µg/mL) 
Percentage 
recovered 
(%) 
Average 
percentage 
recovered 
± S.D  
% 
R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
14.92 
 
14.92 
 
14.92 
12 
 
15 
 
18 
27.01 
 
30.05 
 
33.01 
12.09 
 
15.13 
 
18.07 
100.0 
 
100.10 
 
100.0 
100.00% 
± 
0.057716 
0.0577 0.0064
TABLE.20 
INTRADAY AND INTERDAY PRECISION ANALYSIS OF FORMULATION 
(PRILYXET 30) BY VISIBLE SPECTROPHOTOMETRICMETHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
Labeled 
obtained 
(mg/tab) 
Percentage 
obtained 
(%) 
S.D 
(+/-) % R.S.D 
Intraday Interday Intraday Interday Intraday Interday 
1. 30 101.7 101.7 
0.305505 2.080865 0.300595 2.072575 2. 30 101.9 98.0 
3. 30 101.3 101.5 
TABLE.21  
RUGGEDNESS ANALYSIS OF FORMULATION (PRILYXET 30) BY VISIBLE 
SPECTROPHOTOMETRICMETHOD 
 
 
S.No Condition 
Average 
percentage 
obtained (%) 
S.D 
(+/-) 
%R.S.D S.E 
1. Analyst 1 101.12 
0.091924 0.090847 0.022981 
2. Analyst 2 101.25 
3. Instrument 1 101.9 
2.12132 2.112869 0.53033 
4. Instrument 2 98.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE.22 
OPTICAL CHARACTERISTICS OF DAPOXETINE BY HPTLC METHOD 
 
 
 
 
 
 
 
 
 
 
 
S.No Parameters HPTLC method 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
7. 
 
 
8. 
 
λmax (nm) 
 
Beer’s law limit (µg/mL) 
 
Correlation coefficient (r) 
 
Regression equation (Y=mx+c) 
 
Slope (m) 
 
Intercept (c) 
 
Sandell’s sensitivity 
(µg/cm2/0.001 A.U.) 
 
Standard error of mean 
 
 
292 nm 
 
5-30 
 
0.9995 
 
         Y= 1288.04881 x + 131.6392 
 
1288.04881 
 
                         131.6392 
 
7.76461 
 
 
4.18044 
 
TABLE.23 
QUANTIFICATION OF FORMULATION (PRILYXET 30) BY                     
HPTLC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.
No 
 
Labelled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)
Percentage 
obtained 
(%) 
Average 
percentage 
found 
S.D 
(+/-) %R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
 
30 
 
30 
 
30 
 
30.11 
 
30.21 
 
30.06 
 
100.38 
 
100.78 
 
100.21 
 
 
 
100.45 
 
 
 
 
 
0.2926 
 
 
 
0.2913 
 
 
 
0.0325 
 
TABLE.24 
RECOVERY STUDIES OF FORMULATION (PRILYXET 30) BY               
HPTLC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.
No 
 
Amount 
present 
(µg/ML) 
Amount 
added 
(µg/ML) 
Amount 
estimated 
(µg/ML) 
Amount 
recovered
(µg/ML) 
Percentage 
recovered 
(%) 
Average 
percentage 
recovered 
± S.D  
% 
R.S.D S.E 
 
1. 
 
2. 
 
3. 
 
 
3.06 
 
3.06 
 
3.06 
 
 
2.4 
 
3.0 
 
3.6 
 
5.45 
 
6.07 
 
6.63 
 
2.39 
 
3.01 
 
3.57 
 
99.59 
 
100.33 
 
99.16 
99.69% 
± 
0.591805 
0.5936 0.0657
TABLE.25  
RUGGEDNESS ANALYSIS OF FORMULATION (PRILYXET 30) BY  
HPTLC METHOD 
 
 
 
 
 
 
S.No 
Labeled 
obtained 
(mg/tab) 
Percentage 
obtained 
(%) 
S.D 
(+/-) % R.S.D 
Intraday Interday Intraday Interday Intraday Interday
1. 30 
 
100.2 
 
100.1 
0.55075 0.30550 0.54711 0.3043892. 30 100.7 100.7 
3. 30 100.1 100.3 
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